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ABSTRACT
Research has focused extensively on the negative health effects of inadequate Mg intake,
but the extent of the problem of deficiency deserves further exploration. The notion that U.S.
adults consume an inadequate amount of magnesium, leading to increased risk for chronic
diseases such as depression, is plausible. National Health and Nutrition Examination Surveys
(NHANES), which are large, cross-sectional, population-based data sets that assess the health and
nutritional status of U.S. adults and children, indicate over half the adult population does not
consume adequate amounts of magnesium based on the estimated average requirement (EAR)
established by the Institute of Medicine. Using 2007 to 2010 NHANES data we found 54% of
adults do not meet the EAR, confirming results from earlier surveys. As a result of this finding, a
review exploring the factors impacting magnesium consumption over time and the adequacy of
current intake in U.S. adults was conducted. Changes in agricultural processes that reduce
magnesium levels in crops combined with the increasing consumption of processed foods
containing little to no magnesium have led to a decrease in mean daily intake by 200-300 mg per
day over the past century. However, population-based studies show a steady and consistent
recovery in magnesium intake in U.S. adults over the past several decades. A simple, rapid,
accurate test for whole body Mg status is lacking and, although population-based studies have
limitations, continued monitoring of Mg consumption is essential to determine whether this
positive trend continues. In the meantime, since the health consequences of inadequate
magnesium are well established, there are no reported cases of hypermagnesemia from food
alone, and magnesium is found in healthy foods adults should consume more often, there are few
reasons not to encourage increased magnesium intake.
Cross-sectional and prospective trials in other countries report an association between
magnesium intake and symptoms of depression. Depression is a chronic disease affecting a
significant portion of the U.S. population. Magnesium plays a role in many of the pathways
involved in the pathophysiology of depression and is found in several enzymes, hormones, and
neurotransmitters. Depression and magnesium are both associated with systemic inflammation.
Current treatment options for depression are limited by efficacy, cost, availability, side effects,
and acceptability to patients. As a result of the need for additional treatment options, interest in
the role of magnesium in modulating depressive symptoms has grown. We used the NHANES
2007-2010 data to examine this relationship in U.S. adults and found a significant association
between very low magnesium intake and symptoms of depression (RR=1.16; 95% confidence
interval (CI) 1.06, 1.30; P=0.03). Whether inadequate magnesium leads to increased risk for
depression or depression results in poor dietary intake is not known.
To test whether supplementation with over-the-counter magnesium chloride improves
symptoms of depression, an open-label, blocked, randomized, cross-over trial was carried out in
outpatient primary care clinics on 126 adults (mean age 52; 38% male) diagnosed with, and
currently experiencing, mild-to-moderate symptoms. Consumption of magnesium chloride tablets
for 6 weeks resulted in a clinically significant net improvement in depression (Patient Health
Questionnaire-9) scores of -6.0 points (95% CI -7.9, -4.2; P<0.001) and net improvement in
anxiety (Generalized Anxiety Disorders-7) scores of -4.5 points (95% CI -6.6, -2.4; P<0.001).
Effects were observed regardless of age, gender, baseline magnesium levels, baseline severity of
depression, or use of antidepressant treatments. It worked quickly, was well tolerated, and is
much safer and less expensive than conventional treatments with medication. Magnesium
supplements are effective for mild-to-moderate depression and are an additional treatment option
for patients suffering from depression.
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CHAPTER 1: Factors Influencing Magnesium Consumption in U.S. Adults

Emily Tarleton, MS, RD
Center for Clinical and Translational Science, University of Vermont
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Abstract
Research has focused extensively on the negative health effects of inadequate
magnesium (Mg) intake, but the extent of the problem of deficiency deserves further
exploration. The notion that U.S. adults consume an inadequate amount of magnesium,
leading to increased risk for chronic diseases, is plausible. Large, cross-sectional,
population-based data sets indicate over half the adult population does not consume
adequate amounts of magnesium. Changes in agricultural processes that reduce
magnesium levels in crops combined with the increasing consumption of processed foods
containing little to no magnesium have led to a decrease in mean daily intake over the
past century. However, recent population-based studies show a steady and consistent
recovery in magnesium consumption over the last several decades. A simple, rapid,
accurate test for whole body Mg status is lacking and, although population-based studies
have limitations, continued monitoring of Mg consumption is essential to determine
whether this positive trend continues. In the meantime, since the health consequences of
inadequate magnesium are well established, there are no reported cases of
hypermagnesemia from food alone, and magnesium is found in healthy foods adults
should consume more often, there are few reasons not to encourage increased magnesium
intake.
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Introduction
The effect of inadequate magnesium (Mg) intake on health is well established
and includes electrolyte, neuromuscular, neurologic, and cardiovascular abnormalities.1-4
Adequate intake of Mg is essential due to the mineral’s role in energy production,
prevention of dysrhythmias, blood pressure regulation, insulin resistance, and bone
homeostasis.2,5,6 A simple, rapid, accurate test for whole body Mg status is lacking and,
as a result, monitoring Mg status in U.S. adults is difficult,7 butMg consumption has
reportedly decreased over the past century by 200-300 mg per day.8-10 The possible
reasons for this decrease are multifaceted and include changes in agricultural processes
and food consumption patterns. Mg homeostasis in humans is influenced not only by
dietary intake but also by absorption in the gastrointestinal (GI) tract and excretion by the
kidneys.11 However, further research is needed to draw any conclusions as to the extent
of these factors on net Mg levels. If population-based studies, which use 24-hour recall
data to track intake over time, support the idea of an increasingly Mg deficient
population, the negative health effects are a public health concern.4,7 The aim of this
paper is to explore the factors impacting Mg consumption over time and the current
adequacy of intake in U.S. adults.
Magnesium Basics
Mg, as the fourth most abundant mineral and second most abundant cation in the
human body, has numerous essential roles.12 In addition to being a cofactor for over 300
enzymes, it is essential for anaerobic and aerobic energy generation, glycolysis,
3

mitochondrial oxidative phosphorylation, regulating movement of potassium, and acts as
nature’s physiological calcium channel blocker.13 Mg is an essential mineral that plays a
role in the physiological function of the heart, brain, and skeletal muscles. The human
body contains ~25 grams of Mg with 50-60% found in bone, which is responsible for
maintaining normal extracellular magnesium concentrations, while the rest is found
mostly in skeletal muscle and soft tissue.6 The GI tract and kidneys are the organs
primarily responsible for Mg homeostasis. When dietary intake of Mg is low the percent
absorbed from the diet by the GI tract increases and the amount excreted by the kidneys
decreases to replenish stores.6 After consumption, around 30% is absorbed by the
intestine, 5% is eliminated in feces, approximately 30% is used to replenish stores in
bone, muscle, and other parts of the body, 30% is excreted via urine, and small amounts
are lost via sweat.13
Assessing Magnesium Status
Bone and muscle are the two main compartments for storage and, because they
are not easily or painlessly accessible, an accurate test for whole body Mg status is
lacking.7 Clinical lab tests for assessing Mg include total serum Mg concentration (SMC)
and 24 hour urine excretion. Normal serum levels are 0.75-0.95 mmol/L (1.8-2.3mg/dl).6
Only 1% of total body magnesium is present in extracellular fluids and only 0.3% is
found in serum.11 While SMC is the most convenient and economical way to measure
magnesium, it is not reflective of intracellular magnesium levels14 and does not reflect
bone stores, which might be dangerously low as the body uses them to preserve serum
levels.6,15 SMC can also be low while total body stores are adequate as when a person is
4

taking a drug that acutely increases excretion of Mg.16 Twenty-four hour urine excretion
is readily available, but it is a better assessment of magnesium wasting by the kidneys
and not necessarily a test to assess Mg status.16 Mg in urine most likely shows the
current snapshot of intake and a single 24 hour urinary Mg is not adequate for assessing
Mg status due to the rapidity of change in urinary Mg excretion in response to dietary
intake.7,15
Other potential tests of Mg status are not widely available. Serum concentration
of ionized Mg, the biologically active form, may be the most reflective of current status.7
However, very few clinical laboratories offer this service.16 A Mg retention test, which
assesses the amount of Mg excreted in urine after a parentally administered load test, is
probably the best assessment of Mg deficiency since intracellular levels are
physiologically representative.16 But it is a more invasive technique, is usually limited to
use in research studies, and it is only appropriate for adults with adequate kidney and
intestinal function.6,17 Also of interest, but requiring additional research, are phosphorous
nuclear magnetic resonance (NMR) spectroscopy to measure brain magnesium and total
and free red blood cell Mg concentrations.16,18
Daily Requirements
The response by the body to ensure Mg homeostasis makes it difficult to
determine daily requirements.19 The estimated average requirements (EAR) and
recommended daily allowances (RDA) for Mg intake are based on age and gender (Table
1.1). Current reference values stems from the fact that they were determined by
measuring SMC in healthy normal individuals during data collection for National Health
5

and Nutrition Examination Survey I (NHANES I) in 1974.20 Between 1971 and 1974, the
average serum Mg level in U.S. adults was 0.85 mm/L.20 In this same population a serum
Mg deficiency of 21% in women and 1.5% in men was reported.7,20 Since then there have
been changes in the food supply and prevalence of diseases such as diabetes that affect
Mg status, which may indicate a need to reevaluate daily requirements.7 Reviews of the
adequacy of the EAR question its validity.4,7,15,21 Population studies over the past few
decades assessing both food and supplement sources of Mg indicate a majority of U.S.
adults consume amounts below the EAR (Table 1.2).22-25 In fact, Mg was listed as a
shortfall nutrient in the 2015 Dietary Guidelines, which indicates Mg status in the U.S. is
a public health concern.26 Women consume less Mg than men and black males and
females consume less than their white counterparts, a trend that is well documented going
back to the 1970s.20
Clinical Significance of Deficiency
The clinical consequences of inadequate Mg status have been reviewed
extensively.1-4 Hypomagnesaemia is associated with electrolyte, neuromuscular,
neurologic, and cardiovascular abnormalities.27 Mg plays a role in myocardial energy
production, prevention of dysrhythmias, and promoting vasodilation.5 Increased
consumption of Mg can aid in treatment of CVD and prevention of sudden cardiac
death.2,4 Correcting Mg status can help control blood pressure and reduce risk factors for
CVD, especially in those with hypertension and those that are depleted in Mg due to
diuretic use or poor dietary intake.2 Mg intake and serum Mg concentration are inversely
proportional with c-reactive protein (CRP) levels.4 CRP, a measure of inflammation, is
6

associated with risk of cardiovascular disease (CVD), metabolic syndrome, and diabetes.4
This relationship with inflammation may help explain why inadequate intake and
hypomagnesaemia are associated with CVD, arrhythmias, heart failure, diabetes, and
metabolic syndrome.2,28-31 Elevated risk of diseases even with SMC at higher levels than
the present clinical cut off for deficiency further raise the question of the adequacy of the
reference intervals.7 Latent, or subclinical, deficiency is likely associated with risk of
chronic diseases such as hypertension, cardiovascular disease (CVD), diabetes, and
osteoporosis.32
The varied roles of Mg in the body have led to research on its impact on other
chronic health conditions as well. The association between magnesium intake and
depression is well documented.23,33,34 Magnesium plays a role in many of the pathways
involved in the pathophysiology of depression and is found in several enzymes,
hormones, and neurotransmitters and depression is also associated with inflammation.35,36
Recent randomized clinical trials have found supplementation with magnesium improves
symptoms of depression in patient with hypomagnesaemia37 and regardless of baseline
Mg status.38 Mg is involved in bone cell growth and inadequate intakes can lead to
decreased bone formation and loss of bone mass. Animal studies have shown that Mg
levels at 10%, 25% and 50% of adequate intake lead to bone loss, decreased osteoblast
and increased osteoclast activity.4 Adults suffering from migraines tend to be deficient in
Mg and Mg’s role as a smooth muscle relaxant may also make ensuring adequate status a
priority for alleviating symptoms of asthma.5 Recommendations for Mg supplementation
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to alleviate symptoms of these clinical consequences of deficiency are currently under
investigation.
Hypermagnesaemia, on the other hand, is not a concern. Overconsumption of Mg
from food intake alone has never been documented and rarely occurs from intakes from
supplemental Mg in people with adequate kidney function.6

Consumption Patterns
The negative health effects of inadequate Mg intake are not controversial, but the
extent of the problem of deficiency deserves further exploration. The clinical significance
of Mg deficiency in a majority of the U.S. is not inconsequential. A reliable and
convenient clinical test for Mg status is not available to document changes in Mg status
over time. Researchers rely on results from population-based studies to study changes in
daily consumption throughout the past century. Daily intake has decreased from 400-500
mg per day in the early 20th century to 200-300 mg per day in the 21st century.8-10 Dietary
Mg intake is directly related to calorie intake but is influenced by the amount of Mg
absorbed by the plant from the soil. Low Mg status may be an indicator of other
suboptimal dietary and lifestyle patterns, such as inadequate intake of whole grains,
fruits, and vegetables.7 Unhealthy dietary patterns are often influenced by socioeconomic
status.39 Figure 1.1 illustrates the factors influencing Mg homeostasis. The following
sections focus on factors impacting Mg consumption over the past century (Table 1.3). If
the majority of the U.S. adult population is Mg deficient, the reasons for decreased
consumption of Mg may prove to be an area for public health interventions.
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Magnesium in Soil and Crops
A decrease of Mg in the food supply is likely a major contributor to inadequate
consumption of Mg and perhaps chronic latent deficiency.7 The mineral content of food
differs according to the mineral content of the soil they are grown in, how the plant is
grown and harvested, and the amount of processing prior to consumption. Wild plant
foods consumed by hunter gatherers generally maintained higher micronutrient
concentrations than do their domesticated counterparts.40 Historical data of soil fertility
indicate changes in concentrations of minerals in products from the 1940s to the end of
the 20th century. Some studies report median declines of 5-40% or more of minerals in
fruits and vegetables over the past 50 to 70 years.13,41 Magnesium concentrations in
cheese have decreased by 20% and meat by 15% due to decreased Mg in the feed given
to animals.42 The exact change is difficult to quantify due to the methods of purchasing,
pretreating, and analyzing the food items by different researchers.43 None the less,
changes in the amount of Mg in the soil are reflected in crops. To increase the amount of
Mg in food, there needs to be more Mg available in the soil.
The reason for the change in the amount of Mg in crops is hypothesized to stem
from changes in agricultural processes that result in soil induced dilution effect and
genetic dilution effect.41,42 Soil dilution occurs as the result of environmental changes
such as fertilization and irrigation, which tend to decrease concentrations of minerals in
plants.41 Phosphorus from fertilizers can be beneficial to Mg concentrations in the plant at
low doses, but detrimental at very high rates of application.42 Genetic dilution occurs
when plant yield increases as a result of selective breeding.42 This process came about
9

during the “green revolution” in the 1960s and 1970s, which encouraged increased yield
of grains and other crops by 2 to 3 fold in developing countries.41,44 For example, in
fruits, vegetables, and grains approximately 80% to 90% of the dry weight yield is
carbohydrate. When breeders select for a high yield they are selecting for high
carbohydrate yield, with no assurance that any other nutrients are increasing in the same
proportion.41 Mg content in the food supply is affected by these agricultural processes.
Twentieth century wheat can contain almost 30% less Mg.44 Increasing grain yields over
the past 40 years have provided additional food for the human population, but with a
corresponding decrease in the availability of essential nutrients.
In addition to the amount of Mg available to the plant from the soil, factors related
to the presence of other nutrients and the growth of the plant affect the Mg content of
crops. The amount of Mg is influenced by competition with other ions (such as calcium),
elevated concentrations of aluminum (which decreases Mg uptake45), and other factors
that restrict the size of the root system.42 Mg is found in high concentrations in the
chlorophyll of plants,2 but the developing layer of the plant actually becomes a barrier to
absorption and less Mg is absorbed as the plant grows.42 The edible portion of a plant can
also determine Mg intake. Root crops store 25-33% of their Mg content in the tap root,
which is usually not consumed.42 Up to 50% of Mg is stored in the reproductive organs of
plants such as seed or grain and are removed during processing.42
Magnesium in Water
Hard water is frequently considered an important source of Mg42 and can account
for up to 10% of daily intake.2 The amount of Mg consumed from water varies greatly
10

depending on the mineral content of the water supply.1,5 Soft water has decreased
concentrations of dissolved Mg due to the process of distillation.7 To meet the growing
need for potable water, desalination has increased and the Mg content of desalinated
water is less (0.8mg/L) than hard water (20-30 mg/L).46 Geography also plays a role in
the amount of Mg in the water supply. North American bottled and tap water contains
much lower levels of Mg than European counterparts.47 Levels of Mg in water differ
significantly between states and even within areas of the same city.47 Tap water accounts
for two thirds of water consumed at home, but only half of water consumed away from
home.48 Per capita consumption of bottled water in the U.S. has increased from just under
2 gallons in 1976 to over 36 gallons in 2015, an increase of about 6% per year.49,50
Filtered and bottled water contain less Mg than tap water, although, again, amounts vary
greatly by the source of the water since mineral water contains higher amounts than
spring water.47
Changes in Food Patterns
There are no excellent sources (providing 40% or more of the RDA per serving)
or good sources (providing 25% or more of the RDA per serving) of Mg.51 The highest
levels of Mg are found in green vegetables, beans, peas, legumes, nuts, and whole
unrefined grains. Meat, fish, dairy, and fat contain little Mg.52 The amount of Mg in the
U.S. food supply changed from 408 mg in the early 1900s to 349 mg in 1980, a 14%
decrease.53 Increased intake of processed grains and potatoes paired with increases in
dairy, meat, poultry, and fish is thought to be a major reason for the decrease. From 1909-
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1913 to 1980 the supply of protein from vegetables decreased by 33% while protein from
animals increased by 24%, leading to a net reduction in Mg supply.53
With 72% of total energy in the current Western style diet coming from dairy
products, cereals, refined vegetable oils, and alcohol, it is a poor source of Mg and often
contains only 30-50% of the RDA for Mg.2,54 Mg intake is directly related to calorie
intake except when energy comes from high amounts of alcohol or refined sugars and
oils.1 As a result, eating a typical American diet has to include higher amounts of calories
or include supplements to meet Mg recommendations.55 Diets containing at least 3000
calories per day may be needed, in such cases, to achieve adequate intake of Mg from
diet alone, which exceeds the calorie needs of the average adult.56
Sugar plus refined oil makes up over 36% of the U.S. diet.40 Adults in the U.S.
consume a large proportion of total energy from energy-dense, refined sugars such as
cakes, cookies, pies, sodas and soft drinks and consuming large amounts of these foods
reduces the total vitamin and mineral density of the diet.57 Between 1909-1913 and 1980
use of sugars and other sweeteners increased by 50%, 53 and continued to climb. Per
capita consumption of refined sugars in the U.S. increased from 55.5kg in 1970 to 69.1kg
in 2000.40 More recently, mean daily intake has decreased slightly from 21 teaspoons per
day in 2003-2004 to just over 18 teaspoons in 2011-2012.58 From 1909-1999 per capita
consumption of vegetable oil increased by 130%, shortening increased by 136%, and
margarine increased by 410%.40 Changes in animal husbandry practices and decreased
consumption of wild animals over the past two centuries led to the large scale addition of
refined oils to the food supply.40 Fat storage depots of wild animals are mostly saturated
12

fatty acids, while muscle and organ tissues supply mostly poly and mono unsaturated
fats. Year round dietary intakes of high amounts of saturated fat are not possible when
relying on wild animals for meat, due to the seasonal cyclic depletion of saturated fat.
Animal husbandry has made it feasible to prevent this seasonal decline in body fat and to
also slaughter at peak body fat percentage. The discovery of processing procedures that
allow for the storage of products with high concentrations of animal saturated fats
(cheese, butter, tallow, salted fatty meats) allows for year round consumption of these
high fat products.40
Vegetables contain a high amount of Mg, but are consistently under consumed in
the American diet. Use of processed vegetables increased 4 fold during the 20th century,
while consumption of fresh vegetables increased only during the first half of the
century.53 Processing and boiling of vegetables leads to the loss of 80-90% of Mg and
when these foods are the base of a person’s diet, deficiency can occur.1,13 From 19761980 (NHANES II) to 1988-1994 (NHANES III) the percent of adults consuming three
or more servings of vegetables per day increased from 27% to 35%.59,60 NHANES data
from 1999-2002 indicate a small, but significant (P=0.03) decrease in mean daily intake
with only 33% of adults consuming at least 3 servings of vegetables per day.60 Other
population-based studies confirm that vegetable intake stalled and then decreased in the
late 1990s. Behavioral Risk Factor Surveillance System (BRFSS) data from 1990 to 1994
is consistent with the NHANES data from the early 1990s and indicates the percentage of
U.S. adults meeting the guidelines for 5 servings of fruits and vegetables per day
increased from 19% in 1990 to 22% in 1994, but then only increased to 23% in 1996.61
13

BRFSS data from 1994 to 2005 show an overall significant decrease in frequency of daily
consumption of vegetables by U.S. adults from 2.03 times per day to 1.91 times (95%
confidence interval -1.12, -0.10; P<0.001).62 More recent data from BRFSS indicate the
intake of vegetables remains poor. From 2007 to 2010, 13% of the adult population met
the recommendations for daily vegetable intake of at least 1.5 cups per day and in 2013
the percentage decreased to 9%.63
Adults following a vegetarian diet tend to have higher intake of Mg from food.8
Varying degrees of vegetarianism (i.e. lacto-ovo, or pesco-vegetarian) result in higher Mg
consumption compared to a typical Western diet. In comparison to a typical U.S. diet
pattern, a strict vegetarian diet significantly increases the amount of Mg consumed (mean
intake of 509 mg per day vs. 652 mg per day; P<0.05).64 The reason for the higher Mg
intake is most likely a result of higher intakes of vegetables and legumes.65 The percent
of U.S. adults following a vegetarian diet has decreased from 2.3% in 2006 to 1.8% in
2016.66
Breakfast consumption was associated with a predicted increase in daily fruit and
vegetable servings in a rural U.S. population (coefficient 0.255; P<0.001).67 Mg intake is
lowest and prevalence of inadequacy is highest in people not consuming breakfast and
adequate intake is highest in those consuming ready to eat cereals (RTEC).68 The
adequacy seen with consumption of breakfast is thought to be a result of the inclusion of
whole grains and dairy products. Although dairy is not a rich source of Mg, it is
consumed so frequently that is acts as a significant source of Mg in U.S. diets. Dairy and
dairy products provided 18% of daily Mg in the National Food Consumption Survey
14

(NFCS) of 1977-1978 and over 10% of adults’ daily Mg in the Continuing Survey of
Food by Individuals (CSFI) (1989-1991).69,70 While still a large part of the Western diet,
dairy intake has decreased over time. Between 2001 and 2004, 15% of Americans
consumed the recommended daily servings of dairy, but in 2007-2010 only 11% met the
recommendation.71 Changes in the diet to meet the recommended servings predict a
decrease of inadequate Mg intake in U.S. adults from 56% to 33%. The benefits were
especially seen in older adults.71
However, conflicting research has shown that if RTEC and milk products are
consumed more than fruit, vegetables, lean meat, and seafood, the overall micronutrient
density in the diet is lowered.40 The introduction of dairy and cereal grains as staples may
have caused the average micronutrient content of the human diet to decline. The decline
was worsened by milling techniques. In the latter part of the 19th century, nutritional
characteristics of milled grain changed due to the germ and bran being removed during
the milling process.40 Only 16-18% of original Mg in many RTEC remains in the refined
product.18 Diets high in processed carbohydrates result in a significantly lower intake of
Mg.72 For example, a potato without the skin contains a third less Mg than one with skin.
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White bread and cooked white rice contain almost a third less Mg than their whole

grain counterparts.52 From 2003-2004 to 2011-2012, a small but significant increase in
the consumption of whole grains was seen in the U.S. population (0.6 g to 0.9 g
equivalent per day; P<0.01). Nevertheless, consumption is still far below the
recommendation to consume 50% of grains as whole.58 These counter points regarding
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dairy and RTEC intake reinforce the need to promote a balanced diet of various whole
foods to attain nutritional adequacy.
Intake of beans, legumes, nuts, and seeds has remained mostly constant
throughout the 21st century.53 Between 2009 and 2010 40% of U.S. adults consumed nuts
on a given day, but only 6% of the U.S. population consumes tree nuts regularly.73 Tree
nuts, similarly to dairy, are a great source of shortfall nutrients. Ninety-two percent of
people eating tree nuts consume the EAR for Mg, compared to 40% of non-consumers
and tree nut consumers exhibit a diet pattern of higher quality and nutrient adequacy
overall.54 Between 2005 and 2012 daily consumption of nuts and seeds has increased
slightly (0.60 ounce equivalents to 0.70 ounce equivalents) as has the intake of legumes
(0.09 cups to 0.12 cups).74 While changes in consumption of these food items are not a
reason for an overall decline in adequate Mg intake, they offer the potential for
improving nutrient adequacy in the U.S. diet.
Magnesium Supplements
Supplements can be a major contributor to overall vitamin and mineral intake. In
1986, 15% of the population was taking an over the counter Mg supplement. The most
common amount was 100 mg, although daily intake and the form of Mg was not
confirmed.6 A review of Mg supplement intake in the following decades using NHANES
data shows that as of 2011-2012 Mg supplement use has increased to 28% of the
population, although this is down from a high of 37% in 2005-2006.75 Use is consistently
higher in females6,75 and increases with age.76 People using supplements tend to consume
healthier diets and have higher intakes of Mg from food as well.48,76 Older adults taking
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supplements are three times as likely to have adequate intake and older adults consuming
a supplement also consume twice as much Mg from food alone.48
Socioeconomic Status
Individuals with a higher socioeconomic status (SES) consume healthier diets.77
Higher income and education are associated with higher consumption of reduced or
nonfat milk, lean meats, whole grains, and with consuming at least five servings of fruits
and vegetables per day, while low SES is associated with higher consumption of refined
grains and added fats.39,60,77 Low educational status is associated with low earning
potential, low purchasing power, and food insecurity.39 The prevalence of food insecurity
has remained stable at just over 14% throughout the 21st century.26 Food costs are a
barrier to consumption of nutrient dense foods in low SES groups.77 Food insecure adults
consume vegetables fewer times per month than food secure adults (69 vs. 76; P<0.05).78
The need to maximize calorie intake and minimize food waste leads to not only the
consumption of highly processed, shelf stable foods but also minimal variety.77 The price
of fruits and vegetables has increased more than foods high in sugar and fat in the past 20
years.77,78 The increase in price affects those living in poverty to a greater extent and
decreases access to healthy food. The disparity between SES and fruit and vegetable
intake has increased over time. Results from the 5 A Day for Better Health Program
indicate that though awareness of the program encouraging consumption of fruits and
vegetable in the 1990s increased, intake declined in non-white racial and ethnic groups.79
This finding may help explain the change in vegetable intake at the end of the 20th
century. Americans living in poverty are more likely to be food insecure.78
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Higher SES groups tend to consume higher amounts of most vitamins, minerals,
and fiber regardless of overall energy intake.77,80 NFCS from the 1970s through the 1990s
indicate individuals living in poverty consume less Mg.69 Gender, race, age, income and
education level are associated with Mg intake as well as poverty level.24,25,80,81 NHANES
III (1988-1994) data indicate older adults experiencing food insecurity consume only
58% of the RDA for Mg while their food secure counterparts consume 77% of the RDA
(P<0.05).78 Older adults in the U.S. with higher income meet the EAR for Mg to a
significantly higher extent than those with low income (39% vs. 22%; P<0.05) due to a
healthier overall diet pattern.39 NHANES 2011-2012 data indicate that the prevalence of
U.S. adults meeting the EAR is greater for those with the highest income (~72%) versus
those living in poverty (~50%; P<0.001) and those living in poverty are also less likely to
take any dietary supplement (63% of those with higher income vs. 52% in the lowest
poverty group; P<0.001) .82 Although it is important to note that over half of adults in the
high-income group still consume less than the EAR, and many well-educated, healthy
adults also consume inadequate amounts of Mg.83
Mean changes in Mg intake over time
The data to this point supports the idea of a population with less access to and less
consumption of Mg compared to the previous century. However, when comparing the
NFCS from 1977-1978 and the NHANES from 2013-2014, mean Mg intake in men 20
years and older increased from 283 mg per day to 345 mg per day and in women of the
same age from 204 mg per day to 268 mg per day (Figure 1.2; Joseph Goldman, MA,
Food Surveys Research Group Agricultural Research Service, United States Department
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of Agriculture, email communication, April 18, 2017). The data is consistent with the
research indicating mean consumption in U.S adults is 200-300 mg per day, a decrease
from a mean of 400-500 mg per day a century ago.8-10 Yet, despite evidence to the
contrary, Figure 1.2 indicates overall Mg intake in U.S. adults is recovering. These
surveys confirm women consume less Mg than men and indicate older adults and females
aged 20-29 years still do not currently meet the EAR, but mean intake in these age groups
continues to increase along with the rest of the population.

Evidence for Inadequate Mg Status
The contradictory information gathered here does not resolve the question as to
whether U.S. adults consume adequate amounts of Mg. According to several populationbased studies investigating Mg intake in U.S. adults since the start of the 21st century, a
majority do not consume the EAR. There is population-based data reviewing changes in
dietary patterns and other factors affecting Mg consumption to support this conclusion.
U.S. adults are consuming more amounts of processed grains, oils, and sugar, animal
sources of protein, relying on soft water and bottled water more often, and consuming
fewer fruits and vegetables and Mg supplements. At the same time, according to
agricultural research, the amount of Mg in food is decreasing as a result of changing crop
management practices. Yet 24-hour recall data from population-based surveys indicate an
overall increase in Mg intake in all adults with mean intake reaching the EAR as of 2014.
Due to the limitations of consumption data from population-based studies, results
should be interpreted with caution. Over the years, the way in which intake data is
analyzed changes or differs by investigator and comparing results is difficult. Some
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studies group foods according to conceptually and nutritionally similar characteristics,
but do not disaggregate food mixtures.84 The result is potentially inflated values for some
macro and micronutrients.70 Other studies separate food mixtures into individual
ingredients and are then able to assess the nutrient contribution of each food, which
results in a more accurate portrayal of percent distribution.70 Comparing studies using
differing methods may result in flawed conclusions about changes in consumption over
time. Methods of surveys themselves can make it difficult to compare data if they do not
properly weigh the data to the national population and use methodology that considers
the complex sample design.85 The 24-hour recall is the most common dietary data
collection instrument used in surveillance and is the tool used in What We Eat in
America (WWEIA), the dietary component of the NHANES.86 A limitation of the 24hour recall is that intake varies greatly from day to day and is not indicative of long term
intake, although at the population level, it is thought to provide valid estimates of nutrient
intake.87 Interviewer training and interviewer inter reliability is also a limitation of 24hour recalls. Decisions about the degree of probing for additional details for foods or
recipes, as well as the use of default ingredients in recipes, impact the results. Trained
interviewers are utilized for WWEIA and methods are validated.88
The availability of reliable food composition databases to analyze 24-hour intake
data, in addition to appropriate statistical modeling to calculate the distribution of usual
intake in a population, is essential to producing accurate dietary recall data.86 There is
evidence that the Mg in food has decreased over time due to agricultural processes. The
amount of Mg reported in food varies with the seasons and can change frequently due to
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manufacturer reformulations. Food composition data used to analyze intake must be
continuously updated to reflect these changes. The United States Department of
Agriculture (USDA) provides the food and nutrient databases used for population-based
analyses. The National Database for Standard Reference (SR) is the main source of food
composition data in the U.S.89 It is updated annually and data are derived from USDA
contracted analyses, the food industry, and the scientific literature. The Food and Nutrient
Database for Dietary Studies (FNDDS) provides nutrient values and weights for typical
food portions and is the underlying database for analyzing 24 hour recalls from survey
responders in WWEIA.89 There are no missing values in FNDDS and it is updated
biennially. The nutrient values for the FNDDS are derived from SR. Food composition
data are integral to the success of all federal dietary surveys by the USDA and
Department of Health and Human Services. The ability of the agencies to keep pace with
changes in the U.S. food system is commendable, but the databases are limited by the
high cost of food analysis coupled with funding constraints.90
The Nutrition Data Set for Research (NDSR) is a Windows-based program
designed for the collection and analysis of 24-hour dietary recalls, food records, menus,
and recipes. It combines data from the USDA, food manufacturers, and scientific
literature and includes more individual products than the FNDDS.90 The database,
developed and supported by the Nutrition Coordinating Center at the University of
Minnesota, is used frequently in nutrition research. Due to the importance of knowing the
nutrient content of food items, a recent study compared phosphorous values reported in
NDSR for 46 products with results from a food analysis laboratory.91 The results
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indicated 78% of the products had higher levels of phosphorous than the NDSR reference
values. This small study investigated the potential effects of inaccuracies in the nutrient
database on study results. While it involved only one nutrient, it points to the possible
limitations of current nutrient databases used in research and the ability to use results to
make decisions about the nutritional status of the population.

Future Directions
In early 2015, as a result of the Dietary Guidelines Advisory Committee listing
Mg as a shortfall nutrient, a workshop convened in the U.S. to assess the evidence for the
need to revise the serum magnesium reference level. The group concluded that adequate
scientific data exists to warrant an increase in the reference level to improve clinical care
and public health.7 To determine the reference level, a validated biomarker that most
reflects Mg status is needed; whether it is a dietary, urinary, serum, or a combination
marker is unknown. Other recommendations from the group include addressing methods
of improving intake of Mg in crops and packaged foods, increasing public emphasis and
education on the importance of Mg in the diet, and the development of systems to
monitor Mg insufficiency.7 While the development of a validated biomarker is essential,
it will not be achieved quickly. The other recommendations are either already being
implemented as part of larger public health initiatives or could be relatively easily.
Increasing the nutrient content of crops, minimizing loss during processing, and
preserving nutrients during transport is possible. The amount of Mg that plant foods
provide can be greatly improved by increasing the availability of Mg during growth and
production.92 Mg applications to the soil take time to become incorporated into crops;
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however, foliar sprays of Epsom salts can increase Mg content of plants within 6 weeks.93
Agronomic practices that encourage supplying adequate nutrients to the plant during
vegetation, increasing the percent of edible plant parts, and use of high efficiency
fertilizer along with low leaching techniques are additional suggested techniques for
increasing Mg in food.42 The quality and nutrient content of fruits and vegetables is also
determined by the characteristics of the supply chain (time since harvest and type of
processing).94 Preservation methods can reduce the nutritional losses and increase shelf
life, minimizing the impact of “food miles”.94
Consuming a variety of foods high in Mg should be encouraged in all adults,
regardless of the presence of lifestyle factors or chronic diseases that increase the risk of
deficiency. Eating more whole grains, vegetables, legumes, nuts, and seeds can lead to
higher intakes of Mg and other short fall nutrients. Decreased reliance on refined sugar
and oils also decreases the risk of Mg deficiency. Modeling of various dietary scenarios
indicate increasing plant foods by 100% of current intake and eliminating animal
products decreases the percentage of people with inadequate Mg intake by 5-8%.95
Increasing dairy products by 100% without changing the amount of intake from plant
foods decreases the rate of inadequate Mg by 12%, but this model also increases calorie
intake by almost 200 calories per day in.95 An increase in total calorie intake with
increased dairy intake would need to be counterbalanced with other dietary or lifestyle
changes. The total amount of calcium consumption should be taken into account when
recommending dairy to increase Mg intake, since very high calcium intake competes with
Mg for absorption.55
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Increasing the Mg concentration in the plant, and thus how much is consumed,
might be more feasible than changing eating patterns since evidence that simply
increasing awareness and knowledge of good nutrition practices leads to long term
behavior change is lacking.96 Education level can affect not only purchasing power but
also exposure and understanding of dietary information and healthy behavior messages.80
Strategies to encourage healthy eating patterns must be continually evaluated and revised
to stay current with changes in the market and consumer needs. Due to the lower intake
of Mg in minority groups, future programs hoping to improve diet patterns, and thus
increase Mg intake, should focus not only on awareness around the benefits of increasing
consumption of vegetables, legumes, nuts, and seeds but also the cultural aspects of
dietary preferences.97,98
Not addressed by the working group is the use of supplements to fill the gap
between food intake and the RDA. There have been no reported cases of
hypermagnesemia from food alone, even in people with inadequate kidney function, and
toxicity from supplements is rare.6 Supplements can play a large role in meeting Mg
needs.83 Adults whose diet or medical history put them at higher risk for deficiency may
benefit from Mg supplements in a highly absorbable forms, such as Mg salts. Generally
tolerated in doses below the upper tolerable limit of 350 mg per day in those with
adequate kidney function, higher doses can cause GI upset.6 GI upset acts as a limiting
factor in the amount of Mg that is consumed and leads to decreased intake or termination
of consumption prior to reaching toxicity levels. Changes in SMC occur within weeks of
initiation of Mg supplementation.16
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A diagnosis of hypomagnesaemia due to inadequate dietary intake alone is rare.1
As discussed, this may partly be due to the body’s ability to utilize stores and maintain
adequate SMC in times of deficiency. Several factors increase the requirement for Mg
due to decreased absorption or increased excretion. However, many of the causes are not
well understood or are not easily modifiable. Compounds in food such as phytic acid,
oxalic acid, and protein, chronic conditions such as diabetes and gastrointestinal
disorders, and behaviors such as smoking and alcohol consumption, as well as aging and
medications may impact Mg absorption and excretion.6,43,99-102 More research to
determine the overall effect of these factors on net Mg levels is needed. Increasing Mg
consumption through changes in agricultural processes and consumption of whole foods
is likely a more realistic approach to ensuring adequate Mg status in U.S. adults at this
time.

Conclusion
Until a valid biomarker for Mg status is discovered, continued monitoring of Mg
intake via future population-based studies is essential. Despite the potential for deceased
Mg intake as a result of changes in agricultural practices and dietary patterns, mean Mg
intake in U.S. adults has improved over the past 40 years. However, positive dietary
trends can stall and then decline and continued monitoring is essential. In the meantime,
since there are no reported cases of hypermagnesemia from food alone, the health
consequences of inadequate Mg are well established, and Mg is found in healthy foods
adults should consume more often, there are few reasons not to encourage increased Mg
intake from food. A public health campaign directed solely at Mg consumption in
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addition to those to increase fruit, vegetable, and whole grain consumption is most likely
not needed at this time.

26

Table 1.1 United States published requirements for magnesium6
Age
Male
Female
Pregnancy
Lactation
Estimated Average Requirement
19-30 years
330
255
290
255
31-50 years
350
265
300
265
51-70 years
350
265
>70 years
350
265
Recommended Dietary Allowance
19-30 years
400
310
350
310
31-50 years
420
320
360
320
51+ years
420
320
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Table 1.2 Percentage of adult population with intake below the EAR for
magnesium
NHANES
Magnesium
Ages
% Below
Reference
Years
Source
Included
EAR
Represented
Moshfegh, et al. (2005)81
2001-2002
food
19+
Male
64%
Female
67%
25
Moshfegh, et al. (2009)
2005-2006
food
19+
Male
53%
Female
56%
food +
Tarleton & Littenberg (2015)23
2007-2010
supplements
20+
54%
food +
Papanikoloau, et al. (2015)24
2007-2010
supplements
19+
White
43%
Male
44%
Female
41%
Black
69%
Male
69%
Female
69%
94
Cifelli, et al. (2016)
2007-2010
food
19+
56%
Abbreviations: NHANES, National Health and Nutrition Examination Survey; EAR,
Estimated Average Requirement
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Figure 1.1 Factors influencing magnesium homeostasis
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Table 1.3 Dietary factors negatively influencing consumption of magnesium:
20th to 21st century
Decreased
• Magnesium in soil
• Magnesium in crops
• Consumption of plant based diets
• Consumption of dairy products
Increased
• Consumption of soft water and bottled water
• Reliance on animal protein
• Use of refined sugar and oils
• Consumption of processed grains and vegetables
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Figure 1.2 Magnesium intake in U.S. adults over timea

400

Mean Daily In take of Mg (mg)

350
300
250
200
150
Males
100
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0
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Year of
a

2000
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Surveyb

SOURCE: Joseph Goldman, MA, Food Surveys Research Group Agricultural Research
Service, United States Department of Agriculture, email communication, April 18, 2017.
All estimates from first day of intake collection which was collected in person. All
statistics weighted to represent the national population using methodology that
considered the complex sample design.
b
National Food Consumption Survey 1977-1978; Continuing Survey of Food Intakes by
Individuals 1989-1991, 1994-1996; What We Eat in America, National Health and
Nutrition Examination Survey 2003-2004, 2007-2008, 2013-2014

31

References
1.
2.
3.
4.

5.
6.

7.

8.

9.

10.
11.
12.
13.
14.

15.

16.
17.

Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev.
2003;24(2):47-66.
Grober U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients.
2015;7(9):8199-8226.
Long S, Romani AM. Role of cellular magnesium in human diseases. Austin J
Nutr Food Sci. 2014;2(10):1-19.
Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United
States: are the health consequences underestimated? Nutr Rev. 2012;70(3):153164.
Beckstrand RL, Pickens JS. Beneficial effects of magnesium supplementation. J
Evid Based Complement & Alt Med. 2011;16(3):181-189.
Institute of Medicine. Dietary Reference Intakes: Calcium, Phosphorous,
Magnesium, Vitamin D, and Flouride. Washington, DC: National Academy Press;
1997.
Costello RB, Elin RJ, Rosanoff A, Wallace TC. Perspective: the case for an
evidence-based reference interval for serum magnesium: the time has come. Adv
Nutr. 2016;7(6):977-993.
Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link
between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res.
1995;41(5):347-359.
Food and Nutrition Board, Commission on Life Sciences, National Research
Council. Recommended Dietary Allowances: Subcommittee on the Tenth Edition
of the RDAs. Washington DC: National Academy Press; 1989.
Marier J. Quantitative factors regarding magnesium status in the modern-day
world. Magnesium. 1982;1(3-15):6.
Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kid J. 2012;5(Suppl
1):i3-i14.
Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr.
2013;4(3):378s-383s.
de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for
health and disease. Physiol Rev. 2015;95(1):1-46.
European Food Safety Authority Panel on Dietetic Products NaA. Scientific
opinion on dietary reference values for magnesium. EFSA Journal.
2015;13(7):4186.
Nielsen FH, Johnson LA. Data from controlled metabolic ward studies provide
guidance for the determination of status indicators and dietary requirements for
magnesium. Biol Trace Elem Res. 2016;177(1):43-52.
Elin RJ. Assessment of magnesium status for diagnosis and therapy. Mag Res.
2010;23(4):S194-198.
Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr.
2008;99(Suppl 3):S24-36.
32

18.
19.

20.
21.

22.
23.
24.

25.

26.

27.
28.
29.
30.

31.

32.

Eby GA, Eby KL. Magnesium for treatment-resistant depression: a review and
hypothesis. Med Hypotheses. 2010;74(4):649-660.
Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in
chronic neuropathic pain: a comparison of ketamine and magnesium chloride.
Pain. 1996;64(2):283-291.
Lowenstein FW, Stanton MF. Serum magnesium levels in the United States,
1971-1974. J Am Coll Nutr. 1986;5(4):399-414.
Hunt CD, Johnson LK. Magnesium requirements: new estimations for men and
women by cross-sectional statistical analyses of metabolic magnesium balance
data. Am J Clin Nutr. 2006;84(4):843-852.
Fulgoni VL, Keast DR, Bailey RL, Dwyer J. Foods, fortificants, and supplements:
where do Americans get their nutrients? J Nutrition. 2011;141(10):1847-1854.
Tarleton EK, Littenberg B. Magnesium intake and depression in adults. J Am
Board Fam Med. 2015;28(2):249-256.
Papanikolaou Y, Brooks J, Reider C, Fulgoni VL. Comparison of inadequate
nutrient intakes in non-Hispanic blacks vs. non-Hispanic whites: an analysis of
NHANES 2007-2010 in U.S. children and adults. J Health Care Poor
Underserved. 2015;26(3):726-736.
Moshfegh A, Goldman J, Ahuja J, Rhodes D, LaComb R. What We Eat in
America, NHANES 2005-2006: usual nutrient intakes from food and water
compared to 1997 dietary reference intakes for vitamin D, calcium, phosphorous,
and magnesium. 2009;
https://www.ars.usda.gov/ARSUserFiles/80400530/pdf/0506/usual_nutrient_intak
e_vitD_ca_phos_mg_2005-06.pdf. Accessed March 13, 2017.
United States Department of Health and Human Services, United States
Department of Agriculture. 2015-2020 Dietary Guidelines for Americans.8th ed.
2015; http://health.gov/dietaryguidelines/2015/guidelines/. Accessed March 7,
2017.
Martin KJ, González EA, Slatopolsky E. Clinical consequences and management
of hypomagnesemia. J Am Soc Nephrol. 2009;20(11):2291-2295.
Geiger H, Wanner C. Magnesium in disease. Clin Kid J. 2012;5(Suppl 1):i25-i38.
Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev.
2010;68(6):333-340.
Moore-Schiltz L, Albert JM, Singer ME, Swain J, Nock NL. Dietary intake of
calcium and magnesium and the metabolic syndrome in the National Health and
Nutrition Examination (NHANES) 2001-2010 data. Br J Nutr. 2015;114(6):924935.
Chacko SA, Sul J, Song Y, et al. Magnesium supplementation, metabolic and
inflammatory markers, and global genomic and proteomic profiling: a
randomized, double-blind, controlled, crossover trial in overweight individuals.
Am J Clin Nutr. 2011;93(2):463-473.
Elin RJ. Re-evaluation of the concept of chronic, latent, magnesium deficiency.
Mag Res. 2011;24(4):225-227.
33

33.

34.

35.

36.
37.

38.

39.

40.

41.
42.
43.
44.
45.
46.
47.
48.

49.

Jacka FN, Overland S, Stewart R, Tell GS, Bjelland I, Mykletun A. Association
between magnesium intake and depression and anxiety in community-dwelling
adults: the Hordaland Health Study. Aust N Z J Psychiatry. 2009;43(1):45-52.
Yary T, Lehto SM, Tolmunen T, et al. Dietary magnesium intake and the
incidence of depression: A 20-year follow-up study. J Affect Disord.
2016;193:94-98.
Maes M. Depression is an inflammatory disease, but cell-mediated immune
activation is the key component of depression. Prog Neuropsychopharmacol Biol
Psychiatry. 2011;35(3):664-675.
Serefko A, Szopa A, Wlaz P, et al. Magnesium in depression. Pharmacol Rep.
2013;65(3):547-554.
Rajizadeh A, Mozaffari-Khosravi H, Yassini-Ardakani M, Dehghani A. Effect of
magnesium supplementation on depression status in depressed patients with
magnesium deficiency: a randomized, double-blind, placebo-controlled trial.
Nutrition . 2017;35:56-60.
Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C. Role of
magnesium supplementation in the treatment of depression: a randomized clinical
trial. PloS one. 2017;12(6):e0180067.
Bowman S. Low economic status is associated with suboptimal intakes of
nutritious foods by adults in the National Health and Nutrition Examination
Survey 1999-2002. Nutrition Res. 2007;27(9):515-523.
Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western
diet: health implications for the 21st century. Am J Clin Nutr. 2005;81(2):341354.
Davis DR. Declining fruit and vegetable nutrient composition: what is the
evidence? Hort Science. 2009;44(1):15-19.
Grzebisz W. Magnesium–food and human health. J Elementol. 2011;16(2).
Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr
Metab Disord. 2003;4(2):195-206.
Rosanoff A. Changing crop magnesium concentrations: impact on human health.
Plant Soil. 2013;368(1):139-153.
Mossor-Pietraszewska T. Effect of aluminium on plant growth and metabolism.
Acta Biochim Pol. 2001;48(3):673-686.
Spungen JH, Goldsmith R, Stahl Z, Reifen R. Desalination of water: nutritional
considerations. Isr Med Assoc J. 2013;15(4):164-168.
Azoulay A, Garzon P, Eisenberg MJ. Comparison of the mineral content of tap
water and bottled waters. J Gen Intern Med. 2001;16(3):168-175.
Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ. Older adults who use
vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and
dietary attitudes. J Am Diet Assoc. 2007;107(8):1322-1332.
Doria MF. Bottled water versus tap water: understanding consumers' preferences.
J Water Health. 2006;4(2):271-276.

34

50.

51.

52.

53.
54.

55.
56.

57.

58.

59.

60.

61.

62.

63.
64.

Gleick P. Bottled water sales: the shocking reality. 2013;
http://scienceblogs.com/significantfigures/index.php/2013/04/25/bottled-watersales-the-shocking-reality/. Accessed May 3, 2017.
Pennington JAT, Youngt B. Sodium, potassium, calcium, phosphorus, and
magnesium in foods from the United States total diet study. J Food Comp Anal.
1990;3(2):145-165.
United States Department of Agriculture, Agricultural Research Service. USDA
National FNutrient Database for Standard Reference, Release 28. 2015.
https://ndb.nal.usda.gov/ndb/. Accessed March 20, 2017.
Welsh SO, Marston RM. Review of trends in food use in the United States, 1909
to 1980. J Am Diet Assoc. 1982;81(2):120-128.
O'Neil CE, Nicklas TA, Fulgoni VL, 3rd. Tree nut consumption is associated with
better nutrient adequacy and diet quality in adults: National Health and Nutrition
Examination Survey 2005-2010. Nutrients. 2015;7(1):595-607.
Flink EB. Nutritional aspects of magnesium metabolism. West J Med.
1980;133(4):304-312.
Lakshmanan FL, Rao RB, Kim WW, Kelsay JL. Magnesium intakes, balances,
and blood levels of adults consuming self-selected diets. Am J Clin Nutr.
1984;40(6 Suppl):1380-1389.
O'Neil CE, Keast DR, Fulgoni VL, Nicklas TA. Food sources of energy and
nutrients among adults in the US: NHANES 2003-2006. Nutrients.
2012;4(12):2097-2120.
Bowman S, Clemens J, Friday J, Thoerig R, Moshfegh A. Food Patterns
Equivalents Intakes from Food: Mean Amounts Consumer per Individual, What
We Eat in America, NHANES 2011-12; Tables 1-4. United States Department of
Agriculture, Agricultural Research Service.
https://www.ars.usda.gov/research/publications/publication/?seqNo115=312662.
2014. Accessed June 8, 2017.
Patterson BH, Block G, Rosenberger WF, Pee D, Kahle LL. Fruit and vegetables
in the American diet: data from the NHANES II survey. Am J Public Health.
1990;80(12):1443-1449.
Casagrande SS, Wang Y, Anderson C, Gary TL. Have Americans increased their
fruit and vegetable intake? The trends between 1988 and 2002. Am J Prev Med.
2007;32(4):257-263.
Li R, Serdula M, Bland S, Mokdad A, Bowman B, Nelson D. Trends in fruit and
vegetable consumption among adults in 16 US states: Behavioral Risk Factor
Surveillance System, 1990-1996. Am J Public Health. 2000;90(5):777.
Blanck HM, Gillespie C, Kimmons JE, Seymour JD, Serdula MK. Trends in fruit
and vegetable consumption among U.S. men and women, 1994-2005. Prev
Chronic Dis. 2008;5(2):A35.
Moore LV, Thompson FE. Adults meeting fruit and vegetable intake
recommendations—United States, 2013. MMWR 2015;64(26):709-713.
Rizzo NS, Jaceldo-Siegl K, Sabate J, Fraser GE. Nutrient profiles of vegetarian
and nonvegetarian dietary patterns. J Acad Nutr Diet. 2013;113(12):1610-1619.
35

65.
66.

67.

68.

69.

70.
71.

72.

73.
74.

75.

76.
77.
78.

Haddad EH, Tanzman JS. What do vegetarians in the United States eat? Am J
Clin Nutr. 2003;78(3 Suppl):626s-632s.
Stahler C. How many adults eat vegetarian? Vegetarian Journal. 2016;(4).
http://www.vrg.org/journal/vj2006issue4/2006_issue4_poll.php. Accessed June 6,
2017.
Johnson CM, Sharkey JR, Dean WR. Eating behaviors and social capital are
associated with fruit and vegetable intake among rural adults. J Hunger Environ
Nutr. 2010;5(3):302-315.
Barr SI, DiFrancesco L, Fulgoni VL, 3rd. Consumption of breakfast and the type
of breakfast consumed are positively associated with nutrient intakes and
adequacy of Canadian adults. J Nutr. 2013;143(1):86-92.
United States Department of Agriculture, Agriculture Research Service, Beltsville
Human Nutrition Research Center, Food Surveys Research Group. USDA
Nationwide Food Surveys, 1935-1998. https://www.ars.usda.gov/northeastarea/beltsville-md/beltsville-human-nutrition-research-center/food-surveysresearch-group/docs/past-surveys/. Accessed April 10, 2017.
Subar AF, Krebs-Smith SM, Cook A, Kahle LL. Dietary sources of nutrients
among US adults, 1989 to 1991. J Am Diet Assoc. 1998;98(5):537-547.
Quann EE, Fulgoni VL, 3rd, Auestad N. Consuming the daily recommended
amounts of dairy products would reduce the prevalence of inadequate
micronutrient intakes in the United States: diet modeling study based on
NHANES 2007-2010. Nutr J. 2015;14:90.
Papanikolaou Y, Fulgoni VLF. Certain grain food patterns are associated with
improved 2015 dietary guidelines shortfall nutrient intakes, diet quality, and lower
body weight in US adults: results from the national health and nutrition
examination survey, 2005–2010. Food Nutr Sci. 2016;7.
Nielsen SJ, Kit BK, Ogden CL. Nut consumption among US adults, 2009–2010.
NCHS data brief. 2014;131:1-8.
United States Department of Agriculture, Agriculture Research Service, Beltsville
Human Nutrition Research Center, Food Surveys Research Group. Food Patterns
Equivalents Database. https://www.ars.usda.gov/northeast-area/beltsvillemd/beltsville-human-nutrition-research-center/food-surveys-researchgroup/docs/fped-data-tables/. Accessed April 10, 2017.
Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in dietary
supplement use among us adults from 1999-2012. JAMA. 2016;316(14):14641474.
Bailey RL, Gahche JJ, Lentino CV, et al. Dietary supplement use in the United
States, 2003–2006. J Nutr. 2011;141(2):261-266.
Darmon N, Drewnowski A. Does social class predict diet quality? Am J Clin
Nutr. 2008;87(5):1107-1117.
Dixon LB, Winkleby MA, Radimer KL. Dietary intakes and serum nutrients
differ between adults from food-insufficient and food-sufficient families: third
National Health and Nutrition Examination Survey, 1988–1994. J Nutr.
2001;131(4):1232-1246.
36

79.

80.

81.

82.

83.

84.

85.

86.

Heimendinger J, Van Duyn MA, Chapelsky D, Foerster S, Stables G. The
national 5 A Day for Better Health Program: a large-scale nutrition intervention. J
Public Health Manag Pract. 1996;2(2):27-35.
Kant AK, Graubard BI. Secular trends in the association of socio-economic
position with self-reported dietary attributes and biomarkers in the US population:
National Health and Nutrition Examination Survey (NHANES) 1971-1975 to
NHANES 1999-2002. Public Health Nutr. 2007;10(2):158-167.
Moshfegh A, Goldman J, Cleveland L. What We Eat in America, NHANES
2001-2002: Usual Nutrient Intakes from Food Compared to Dietary Reference
Intakes. 2005;
https://www.ars.usda.gov/ARSUserFiles/80400530/pdf/0102/usualintaketables20
01-02.pdf. Accessed March 28, 2017.
Bailey RL, Akabas SR, Paxson EE, Thuppal SV, Saklani S, Tucker KL. Total
usual intake of shortfall nutrients varies with poverty among US adults. J Nutr
Educ Behav. 2017;In Press.
Hallfrisch J, Muller DC. Does diet provide adequate amounts of calcium, iron,
magnesium, and zinc in a well-educated adult population? Exp Gerentol.
1993;28(4–5):473-483.
Block G, Dresser CM, Hartman AM, Carroll MD. Nutrient sources in the
American diet: quantitative data from the NHANES II survey. II. Macronutrients
and fats. Am J Epidemiol. 1985;122(1):27-40.
Johnson CL, Paulose-Ram R, Ogden CL. National Health and Nutrition
Examination Survey: Analytic Guidelines 1999-2010. Vital Health Stat.
2013;2(161).
Dodd KW, Guenther PM, Freedman LS, et al. Statistical methods for estimating
usual intake of nutrients and foods: a review of the theory. J Am Diet Assoc.
2006;106(10):1640-1650.

87.

Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J
Nutr. 2003;133(9):2879-2882.

88.

Centers for Disease Control and Prevention. The National Health and Nutrition
Examination Survey Documentation, Codebook, and Frequencies; Dietary
Interview - Individual Foods, First Day. Atlanta, GA: CDC; 2008.
Ahuja JK, Moshfegh AJ, Holden JM, Harris E. USDA food and nutrient databases
provide the infrastructure for food and nutrition research, policy, and practice. J
Nutrition. 2013;143(2):241s-249s.
Schakel SF, Sievert YA, Buzzard IM. Sources of data for developing and
maintaining a nutrient database. J Am Diet Assoc. 1988;88(10):1268-1271.
Moser M, White K, Henry B, et al. Phosphorus content of popular beverages. Am
J Kid Dis. 2015;65(6):969-971.
Nielsen FH. Importance of plant sources of magnesium for human health. Crop
Pasture Sci. 2016;66(12):1259-1264.
Boynton D. Nutrition by foliar application. Ann Rev Plant Phys. 1954;5(1):31-54.
Edwards-Jones G, i Canals LM, Hounsome N, et al. Testing the assertion that
‘local food is best’: the challenges of an evidence-based approach. Trends Food
Sci Technol. 2008;19(5):265-274.
37

89.

90.
91.
92.
93.
94.

95.

96.
97.

98.

99.

100.
101.

102.

Cifelli CJ, Houchins JA, Demmer E, Fulgoni VL. Increasing Plant Based Foods
or Dairy Foods Differentially Affects Nutrient Intakes: Dietary Scenarios Using
NHANES 2007-2010. Nutrients. 2016;8(7):422.
Hackman RM, Aggarwal BB, Applebaum RS, et al. Forecasting nutrition research
in 2020. J Am Coll Nutr. 2014;33(4):340-346.
Pawlak R, Colby S. Benefits, barriers, self-efficacy and knowledge regarding
healthy foods; perception of African Americans living in eastern North Carolina.
Nutr Res Pract. 2009;3(1):56-63.
Kant AK, Graubard BI. Ethnicity is an independent correlate of biomarkers of
micronutrient intake and status in American adults. J Nutr. 2007;137(11):24562463.
Rude RK. Magnesium. In: Ross AC, Caballero B, Cousins RC, Tucker KL,
Ziegler TR, eds. Modern Nutrition in Health and Disease. 11th ed. Baltimore,
MA: Lippincott Williams & Wilkins; 2010:159-175.
Barbagallo M, Belvedere M, Dominguez LJ. Magnesium homeostasis and aging.
Mag Res. 2009;22(4):235-246.
Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, et al. Proton pump inhibitors
and hypomagnesemia in the general population: a population-based cohort study.
Am J Kid Dis. 2015;66(5):775-782.
La Vecchia C, Negri E, Franceschi S, Parazzini F, Decarli A. Differences in
dietary intake with smoking, alcohol, and education. Nutr Cancer.
1992;17(3):297-304.

38

CHAPTER 2: Magnesium Intake and Depression in U.S. Adults

Emily K. Tarleton, MS, RD and Benjamin Littenberg, MD
University of Vermont Center for Clinical and Translational Science

39

Abstract
Background: Depression is a common and often disabling disorder. Magnesium
supplementation has been linked to improvement in depressive symptoms but consensus
on the relationship between magnesium and depression has not been reached.
Methods: The purpose of this study was to test the existence of an association between
dietary magnesium intake and depression in the adult U.S. population. A cross-sectional,
population-based data set (National Health and Nutrition Examination Survey) was used
to explore the relationship of magnesium intake and depression in 8,894 U.S. adults
(mean age 46.1; 47.4% male) from 2007-2010. Using logistic regression to model the
relationship between the presence of depression (Patient Health Questionnaire Score >5)
and low magnesium intake (<184 mg/day), we examined the risk ratio (RR) of
magnesium intake and its 95% confidence interval.
Results: After adjustment for all potential confounders, the strength of association of
very low magnesium intake with depression was statistically significant (RR=1.16;
95%CI 1.06, 1.30; P=0.026). Adjusting for all other covariates, low magnesium intake
was associated with depression in subjects under age 65 (RR 1.22; 95%CI 1.06, 1.40;
P=0.007), but appeared protective in seniors (RR 0.75; 95%CI 0.56, 0.98; P=0.032).
Conclusions: We found a significant association between very low magnesium intake
and depression, especially in younger adults. The finding of the potential protective effect
of low magnesium intake in older adults is surprising and warrants further investigation.
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Introduction
Depression is a common and disabling disorder. Almost 11% of adults older
than 60 and 18.8% in those younger than 60 suffer from depression.1 Although both
pharmacologic and behavioral therapies are effective for many patients, they have
important limitations. Medications can take weeks to have an effect, often have
significant adverse effects, and fail to help many patients at all.2 Non-pharmacologic
approaches such as Cognitive Behavioral Therapy are also effective3, but require highly
trained therapists and weeks to achieve effectiveness.
As a result of the need for additional treatment options, interest in the role of
nutrition in modulating depressive symptoms has grown. Magnesium plays a role in
many of the pathways involved in the pathophysiology of depression and is found in
several enzymes, hormones, and neurotransmitters.4 Depression and magnesium are both
associated with systemic inflammation.5, 6 National data indicate a significant portion of
the population has magnesium intake below the Estimated Average Requirement (EAR).7
Magnesium supplementation has been linked to improvement in symptoms of
major depression8, premenstrual symptoms9, postpartum depression8 and chronic fatigue
syndrome.10 Low magnesium status has been associated with increased depressive
symptoms in several different age groups and ethnic populations.11-14
Issues in study design have led to inconclusive results and skepticism of
magnesium’s role in depression. Serum magnesium levels were used to indicate
magnesium status in some studies,11, 15 but its reliability is questionable.16, 17 Clinical
trials have suffered from limited sample sizes,10, 11 the use of the supplement magnesium
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oxide,18 which is poorly absorbed,17 and restrictive inclusion criteria.11 With varying
outcomes, different populations and age ranges, and limited sample sizes, consensus on
the relationship between magnesium intake and depression has not been reached.
Some cross-sectional studies have reported an inverse relationship between
magnesium intake and standardized depression scores in populations with low
magnesium intake.12-14, 19 Because these studies were conducted outside of the United
States, their results should be validated in the U.S. population. One longitudinal study20
did not find an inverse relationship, although it was underpowered to detect a significant
reduction in depression.
If proven effective, increased magnesium consumption through diet or
supplementation might address some of the limitations of currently available treatment.
Magnesium is found in many common foods and emphasis on these foods can easily
affect magnesium status. Although it can lead to hypermagnesemia and diarrhea,
magnesium supplementation is, in general, a safe treatment with few unanticipated side
effects. Magnesium supplementation provides very quick results. Case studies of
magnesium supplementation reported improvements in depression, anxiety, and sleep
within one week.8, 11 Therefore, we sought to test the existence of a relationship between
dietary magnesium intake and depression using a large, cross-sectional, population-based
data set from the U.S.
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Subjects and Methods
Data Source and Subjects
To investigate the question of whether there is an association between
depression and magnesium intake, we conducted a cross-sectional study using the
National Health and Nutritional Examination Survey (NHANES). NHANES participants
undergo extensive interviews and laboratory assessments including measures of dietary
intake, dietary supplements, socioeconomic factors, clinical characteristics, and personal
habits.21 By applying the weighting scheme supplied by the Centers for Disease Control
and Prevention, NHANES can be used to represent the sex-, age-, race- and ethnicityadjusted non-institutionalized population of the U.S. To increase the power of the
analyses, we combined the data from two separate waves of the survey (2007-08, and
2009-10).22 We included all subjects at least 20 years old with complete data for the
outcome, predictor, and all the candidate confounders.
Variables
The main predictor variable was total magnesium intake in milligrams (mg)/day
calculated from 24 hour dietary and supplement recall data. Intake was used because of
the unreliability of serum magnesium levels16 and because it is directly modifiable and
could serve as an intervention. Low magnesium intake was defined as intake in the
lowest quintile (<184 mg/day). Magnesium deficiency is defined with age- and sexvarying thresholds taken from the EAR as intake <350 mg/d for men over age 30, <330
mg/d for younger men, <265 for women over age 30, and <255 for younger women.23
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The outcome variable was the Patient Health Questionnaire-9 (PHQ-9) score, a
validated survey tool for measuring the presence and severity of depression in adults.24
The PHQ-9 score is the sum of the responses to nine items representing symptoms of
depression. Each is graded by the patient according to how often they have experienced
the symptoms over the previous two weeks, from 0 (not at all) to 3 (nearly every day).
PHQ-9 scores range from zero to 27 and were dichotomized into depressed (PHQ-9 score
5-27) or not (PHQ-9 score 0-4).
Based on review of the literature and our clinical experience, we considered age,
sex, race, ethnicity, education, marital status, household income, food security, tobacco
use, alcohol intake, diabetes, kidney disease, and folate intake as potential confounders of
the relationship between depression and magnesium intake. Race and ethnicity were
combined into a single dichotomous variable of non-Hispanic white vs. all others.
Education was dichotomized as having a high school diploma (or equivalent) vs. not.
Marital status was characterized as married or living as married vs. single, divorced,
widowed or separated. Household income was dichotomized as low if it was reported to
be $35,000 per year or less. Food insecurity was present if the subject endorsed any of the
following three statements: “(I/we) worried whether (my/our) food would run out before
(I/we) got money to buy more” or “The food that (I/we) bought just didn't last, and (I/we)
didn't have money to get more” or “(I/we) couldn't afford to eat balanced meals.”
Tobacco use was considered present if the patient endorsed current smoking vs. absent
for former smokers and those who never smoked. Alcohol use was coded as the average
number of units consumed per day over the past year. A unit of alcohol is one can of
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beer, one glass of wine, or one ounce of liquor. Non-drinkers were coded zero. Diabetes
and kidney disease were considered present if the patient endorsed that a doctor or other
health professional had told them they had the diagnosis. Folate intake in (micrograms
per day) included dietary folate equivalents of food plus supplements and was
dichotomized at <230 µg/d (the lowest quintile of daily folate intake).
Statistical Analysis
The primary hypothesis was that depression is associated with magnesium
intake while adjusting for possible confounders. We used unadjusted nonparametric
Wilcoxon-type tests of trend to assess the relationships between quintiles of magnesium
intake and other subject characteristics.25 We used logistic regression to model the
relationship between the presence of depression (PHQ >5) and low magnesium intake
(<184 mg/day, the lowest quintile) and tested the hypothesis by examining the odds ratio
(OR) and relative risk (RR)26 on magnesium intake and its 95% confidence interval (CI).
Each potential confounder was tested in a separate univariate logistic regression for
association with the outcome (depression) and the main predictor (low magnesium
intake). If the variable was associated with both outcome and predictor with each P<0.1,
it was considered a potential confounder and included in the multivariate model. We
explored the use of the magnesium as a function of energy (milligrams of
magnesium/1000 calories) as the predictor by following the same procedure. Because
both magnesium intake27 and depression1 vary with age and gender, we constructed
additional models including interaction terms to explore the possibility of interactions of
magnesium with gender and magnesium with age. All analyses employed the
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stratification and weighting scheme recommended for NHANES by the National Center
for Health Statistics22 using Stata13.1 (College Station, TX). P values <0.05 were
considered to be statistically significant.

Results
Of the adult subjects in the NHANES data set, 73% met eligibility criteria, for a
final sample size of 8,894 (see Figure 2.1). The characteristics of the sample are
described in Table 2.1. All the selected covariates showed significant trends across the
quintiles of magnesium intake. Depression was most prevalent in the lowest quintile of
magnesium intake.
The univariate regression of low magnesium intake and depression
demonstrated a strong statistically significant association with an OR of 1.73 (95%CI
1.48, 2.02; P<0.001) and an RR of 1.49 (95%CI 1.35, 1.66; P<0.001) (Table 2.2). All the
potential confounders were associated with both low magnesium and depression (P<0.1)
and were retained in the multivariate model (except household income because it was
highly correlated with food insecurity). After adjustment for all potential confounders,
the strength of association of low magnesium intake with depression was attenuated but
remained statistically significant with an OR=1.21 (95%CI 1.02, 1.42; P=0.026). This is
equivalent to a RR of 1.16 (95%CI 1.06, 1.30; P=0.026). The use of magnesium as a
function of energy gave similar results.
Over half of the population (54%) reported deficient magnesium (intake less
than the EAR). Deficiency was significantly associated with depression in the univariate
model (OR 1.13; 95%CI 1.01, 1.27; RR 1.10; 95%CI 1.01, 1.20; P=0.04) but not in the
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multivariate adjusted analyses (OR 0.97; 95%CI 0.85, 1.09; RR 0.98; 95%CI 0.88, 1.07;
P=0.57).
Only one of the covariates had a significant interaction with depression. Older
age interacted significantly with low magnesium intake (OR 0.51; 95%CI 0.37, 0.72;
P<0.001). Adjusting for all other covariates, low magnesium intake was associated with
depression in subjects under age 65 (OR 1.31; 95%CI 1.08, 1.58; RR=1.22; 95%CI 1.06,
1.40; P=0.007), but appeared protective in seniors (OR 0.69; 95%CI 0.49, 0.97;
RR=0.75; 95%CI 0.56, 0.98; P=0.032) (Figure 2.2).

Discussion
Overall, we found a significant association between low magnesium intake and
depression, especially in younger adults. The increased prevalence of depression was
confined to the lowest levels of magnesium intake. Nonetheless, the effect is very strong,
with a >50% higher rate of depression in the lowest quintile of intake compared to those
consuming greater amounts. A very different pattern was observed in seniors (Figure 2.2
and Table 2.3). First, the overall rates of depression were lower. Second, the spread in
rates across the levels of magnesium intake were much higher for younger adults (23% to
37%) than in seniors (15% to 21%). Third, the lowest quintile of intake among seniors
did not have the highest prevalence of depression. Rather, the highest rates occurred in
the group with the highest intake. Although the adjusted odds of depression were
significantly greater in the highest intake group compared to the lowest quintile (Table
2.3), there was no clear dose-response relationship, and the clinical significance of this
finding is uncertain. The large sample size available for analysis (372 to 435 seniors in
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each quintile of magnesium intake) may be responsible for making a small or even
negligible effect appear statistically significant. Even if we discount the apparent adverse
effect of high magnesium intake in seniors, there is little doubt that the increased
prevalence of depression with low intakes seen in younger subjects is absent after age 65.
By 2030, close to 20% of the population will be older than 65 (up from the current
12.9%).28 Therefore, the number of people with late-life depression will also increase.
Depression later in life increases risk for cardiovascular disease and mortality29-31 and
depressive symptoms lasting more than one year are associated with a significant
increased risk of mortality.29 Newly depressed older adults are at a higher risk for
mortality and those with worsening depression have a 70% increase in mortality risk
compared with patients with stable depression scores.29 Therefore, understanding
modifiable risk factors for depression in the older population is particularly useful.
Our data show over half of adults do not consume adequate amounts of
magnesium. This finding is similar to other U.S. population studies.7 Magnesium
excretion increases while absorption decreases with age32 because of various chronic
diseases and decreased intake of foods high in magnesium. Compared with imipramine,
magnesium supplementation was effective in treating depression in older adults with
hypomagnesaemia and type 2 diabetes in a randomized control trial.11 The current
analysis differs by suggesting a detrimental effect of higher magnesium intake in older
adults. The differences may be because this is a study of a general U.S. population with
low intake rather than a group selected for low serum magnesium concentrations and
diabetes.
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Little is known about the mechanism of the possible effect of magnesium on
depression. Even less is known about this mechanism in elderly and why the association
might differ between age groups. The current findings might be due to unidentified
confounders, reverse causality, or data error. The PHQ has been found to be comparable
with the Geriatric Depression Screen in a convenience sample of elderly primary care
patients.33 However, the existence of an emotional paradox in elders,34 in which older
adults experience higher levels of well-being despite cognitive and physical decline, may
influence how depression is identified and scaled in this group and make the PHQ less
sensitive.
Several studies have looked at whether overall dietary pattern is more important
than specific nutrients when looking at nutrition’s influence on depression. Among adults
with mood disorders, mineral intakes may be associated with psychiatric disorders more
so than vitamin intakes.35 We cannot rule out that a specific dietary pattern or
combination of nutrients would show a synergistic effect and a stronger relationship with
depression than magnesium alone. For instance, residents of Greece, where most people
follow the Mediterranean Diet Pattern, have a lower rate of depression and mental
disorders.36, 37 Changing dietary patterns takes time, however, as well as commitment on
the part of the patient. Emphasis on consumption of high magnesium foods such as green
leafy vegetables, legumes, nuts, seeds and whole grains could offer a dietary approach to
controlling symptoms of depression. Advocating for increased magnesium intake through
food can lead to a healthier overall diet and might be attractive to patients that have
previously experienced unwanted side effects from medications for depression.
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Magnesium supplementation may be effective in as little as one week8 but may lead to
stomach upset such as nausea, vomiting, or diarrhea in some people. However, toxic
levels are unlikely to occur when it is given in the recommended dose and kidney
function is normal.16 Whether increased dietary consumption of magnesium would lead
to an improvement in symptoms just as quickly as supplements is unknown.
Strengths and Limitations
This study has several strengths. The sample size was large and representative of
almost 180 million American adults. The analysis includes the most recent available data
from 2007-2010 and captures both dietary and supplemental intake. Although the
assessment of magnesium intake at only one time point may not reflect long term intake,
trained interviewers were used to collect the data and the methods were validated and
consistent over the four years of data collection.38 In addition to social, demographic,
behavioral and clinical covariates, this analysis also controlled for folate intake, which
has not been included in many previous analyses.
As with all observational studies, we cannot exclude the possibility of additional
confounding not accounted for by the analysis. Likewise, we cannot rule out reverse
causality to explain the association between magnesium intake and depression. In other
words, poor dietary intake of magnesium could be a result of mental illness.

Conclusion
This study enlarges upon previous research finding a relationship between
magnesium intake and depression. Although very low magnesium intake appeared
protective for depression in seniors, it was associated with higher rates of depression in
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younger adults. Rigorous, randomized clinical trials, with adequate power to analyze
subgroups, are needed to confirm the effects of magnesium on depression.
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Figure 2.1 Inclusion flow diagram
NHANES participants
2007-08
2009-10

10,149
10,537

Total

20,686
Age <20
N = 8,533

Missing magnesium intake data
N = 971

Missing PHQ-9
N = 911
Missing 1 or more covariates
N = 1,377
Complete records
analyzed
N = 8,894

NHANES = National Health and Nutrition Examination Survey; PHQ-9 = Patient Health
Questionnaire-9

52

Table 2.1 Subject characteristics by quintile of magnesium intake*
Characteristic

1

Quintile
3

2

4

5

Sample size
N
1,681
1,727
1,834
1,816
1,836
Magnesium intake
Mean (mg/d)
138
216
281
361
581
Range (mg/d)
0-183 184-246 247-315 316-417 418-2,437
Deficient intake
100%
100%
58.5%
18.1%
0%
Depression (PHQ-9 score)
Mean
4.1
3.3
2.8
2.8
2.8
Range
0-27
0-27
0-24
0-25
0-27
Depressed (score >5)
32.2%
24.5%
20.5%
20.5%
21.1%
Age
Mean (y)
44.6
45.8
46.2
46.9
46.5
Senior (age 65+)
16.6%
16.5%
16.7%
14.7%
13.9%
Race and ethnicity
Mexican-American
15.9%
17.4%
18.5%
18.2%
17.7%
Other Hispanic
12.6%
12.4%
11.1%
9.3%
8.7%
Non-Hispanic White
39.2%
44.1%
46.6%
52.1%
57.3%
Non-Hispanic Black
28.7%
21.8%
18.9%
15.9%
12.1%
Other
3.6%
4.2%
4.9%
4.5%
4.3%
Gender
Male
26.9%
38.8%
46.2%
53.5%
63.2%
Social
High school graduate
73.6%
80.8%
82%
86.5%
86.7%
Married (or living as married) 54.9%
58.2%
62.7%
66.1%
68.0%
Food insecurity
23.4%
16.3%
13.5%
11.0%
10.8%
Household income <
47.8%
33.2%
29.6%
23.2%
24.4%
$35,000/year
Habits
Current smoker
31.2%
20.9%
20.5%
20%
17.7%
Mean drinks per day
0.4
0.5
0.5
0.7
0.7
Chronic disease
Diabetes
11%
9.6%
8.4%
8.4%
8.2%
Kidney disease
3.7%
1.9%
1.2%
0.7%
1.1%
Dietary Folate Equivalent
intake
Lowest quintile (< 230 µg/d)
58.6%
23.2%
9.1%
3.4%
1.5%
*The trend across quintiles of magnesium intake is significant with P<0.001 for all
characteristics using an unadjusted nonparametric test of trend.25
PHQ-9 = Patient Health Questionnaire-9
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Total
8,894
334
0-2,437
54%
3.1
0-27
23.2%
46.1
15.5%
17.6%
10.8%
48.1%
19.3%
4.3%
47.4%
82.5%
62.6%
14.4%
30.5%

21.5%
0.6
9%
1.6%

16.5%

Table 2.2 Logistic regressions on depression
Independent Variable
Univariate model
Low magnesium
Multivariate model
Low magnesium
Male
Age 65+
Non-Hispanic white
High school graduate
Married
Drinker
Chronic Kidney Disease
Smoker
Diabetes
Food insecurity
Low folate intake
CI = Confidence Interval

Odds Ratio

95% CI

P

1.73

1.48, 2.02

<0.001

1.21
0.61
0.65
0.95
0.77
0.70
1.06
2.50
1.78
1.63
2.30
1.11

1.02, 1.42
0.53, 0.70
0.54, 0.77
0.68, 1.32
0.64, 0.93
0.61, 0.80
0.99, 1.12
1.66, 3.79
1.52, 2.10
1.29, 2.06
1.90, 2.78
0.92, 1.35

0.026
<0.001
<0.001
0.75
0.007
<0.001
0.073
<0.001
<0.001
<0.001
<0.001
0.28
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Figure 2.2 Prevalence of depression adjusted by magnesium intake and age
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The prevalence estimates for each quintile of magnesium intake for each age group were
adjusted for gender, race, ethnicity, education, marital status, alcohol intake, smoking,
kidney disease, diabetes, food insecurity and low dietary folate. Quintiles of magnesium
intake are labeled as milligrams per day.
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Table 2.3 Adjusted odds of depression by age and magnesium intake*
Magnesium Intake
Odds Ratio
95% CI
P
Age < 65
0-183 mg/day
1
184-246 mg/day
0.81
0.67, 0.98
0.032
247-315 mg/day
0.69
0.52, 0.92
0.012
316-417 mg/day
0.76
0.63, 0.91
0.005
418-2,437 mg/day
0.80
0.59, 1.09
0.15
Age 65+
0-183 mg/day
1
184-246 mg/day
1.38
0.87, 2.18
0.17
247-315 mg/day
1.29
0.79, 2.10
0.29
316-417 mg/day
1.30
0.83, 2.03
0.24
418-2,437 mg/day
2.15
1.34, 3.45
0.002
*Odds ratios and confidence intervals (CIs) were adjusted for sex, race, ethnicity,
education, marital status, alcohol intake, smoking, kidney disease, diabetes, food
insecurity and low dietary folate.
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Abstract
Current treatment options for depression are limited by efficacy, cost,
availability, side effects, and acceptability to patients. Several studies have looked at the
association between magnesium and depression, yet its role in symptom management is
unclear. The objective of this trial was to test whether supplementation with over-thecounter magnesium chloride improves symptoms of depression. An open-label, blocked,
randomized, cross-over trial was carried out in outpatient primary care clinics on 126
adults (mean age 52; 38% male) diagnosed with and currently experiencing mild-tomoderate symptoms with Patient Health Questionnaire-9 (PHQ-9) scores of 5-19. The
intervention was 6 weeks of active treatment (248 mg of elemental magnesium per day)
compared to 6 weeks of control (no treatment). Assessments of depression symptoms
were completed at bi-weekly phone calls. The primary outcome was the net difference in
the change in depression symptoms from baseline to the end of each treatment period.
Secondary outcomes included changes in anxiety symptoms as well as adherence to the
supplement regimen, appearance of adverse effects, and intention to use magnesium
supplements in the future. Between June 2015 and May 2016, 112 participants provided
analyzable data. Consumption of magnesium chloride for 6 weeks resulted in a clinically
significant net improvement in PHQ-9 scores of -6.0 points (CI -7.9, -4.2; P<0.001) and
net improvement in Generalized Anxiety Disorders-7 scores of -4.5 points (CI -6.6, -2.4;
P<0.001). Average adherence was 83% by pill count. The supplements were well
tolerated and 61% of participants reported they would use magnesium in the future.
Similar effects were observed regardless of age, gender, baseline severity of depression,
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baseline magnesium level, or use of antidepressant treatments. Effects were observed
within two weeks. Magnesium is effective for mild-to-moderate depression in adults. It
works quickly and is well tolerated without the need for close monitoring for toxicity.
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Introduction
Depression affects 350 million people worldwide and is predicted to be the
leading cause of disease burden by 2030, based on disability-adjusted-life-year [1]. Initial
antidepressant trials of adequate dose and duration result in only about 50% of patients
achieving remission [2]. Even after the addition of other treatments, 20% still suffer from
symptoms after 2 years. Non-pharmacologic approaches such as Cognitive Behavioral
Therapy and lifestyle interventions require highly trained therapists and several weeks to
months to achieve effectiveness [3]. There is a great need for additional treatment
options.
The association between magnesium intake and depression is well documented
[4-7]. Improvement in depression with magnesium supplementation has been reported
inconsistently [8, 9], although few clinical trials exist. One trial found magnesium
chloride to be effective for depression in seniors with type 2 diabetes [10] while another
trial found magnesium citrate decreased depression in patients with fibromyalgia [11].
One negative trial used magnesium oxide [12], known to be poorly absorbed.
The aim of this study was to test the hypothesis that 6 weeks of oral magnesium
chloride (MgCl2) supplementation will improve symptoms of mild-to-moderate
depression in a primary care population.
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Methods
Trial Design
This was a 12-week open label randomized cross-over control trial. Participants
were recruited through primary care providers (PCPs) within a single academic medical
center and randomized to begin MgCl2 supplementation immediately or at week 7
(delayed). During the other 6-week period, they took no MgCl2. Prior to the start of the
study the Institutional Review Board of the University of Vermont approved the study.
All subjects provided written informed consent. Trial registry can be found at
clinicatrials.gov (Identifier: 02466087).
Participants
The target population was adults with mild-to-moderate depression. Inclusion
criteria were: 1) 18 years of age or older; 2) no change in treatment plan for depression
for the past 2 months and going forward (including no current treatment, stable use of
antidepressant medication, or ongoing nonpharmacologic therapy); 3) Patient Health
Questionnaire-9 (PHQ-9) score of 5-19 [13]. Exclusion criteria were: 1) Schizophrenia,
bipolar disease, active delirium, dementia, kidney disease (due to the role of the kidneys
in magnesium homeostasis), myasthenia gravis (magnesium may worsen symptoms of
the disease), or gastrointestinal (GI) disease (diarrhea is a common side effect of
magnesium); 2) pregnant or trying to get pregnant; 3) planned surgery in the next 3
months; 5) taking a medication known to interact with magnesium; 6) unwilling to stop
taking non-study magnesium supplements for the duration of the study.
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Magnesium supplements
Tablets of MgCl2 (Alta Health Products, Idaho City, ID) were provided free of
charge. Participants were instructed to take four 500 mg tablets of magnesium chloride
daily for a total of 248 mg of elemental magnesium per day. MgCl2 was used because of
its high bioavailability and tolerability compared to other salts [14, 15].
Study procedures and randomization
PCPs reviewed lists of their patients with a diagnosis of depression in their
medical record and indicated which ones may be sent a letter describing the study. PCPs
were encouraged to remove patients from their list if they knew depression was no longer
an active problem, the patient was also suffering from severe mental illness, or the patient
was not able to start or stop taking magnesium. Those patients that did not opt out after
receiving the letter were contacted by phone to determine interest and eligibility.
Eligibility and diagnosis of depression was confirmed with an initial telephone PHQ-9
score between 5 and 19. Participants next met with study staff for a baseline visit during
which they provided written informed consent and baseline data including demographics,
medication use, the PHQ-9 [13], the Generalized Anxiety Disorders-7 (GAD-7) [16], the
Modified Morisky Scale [17] to assess medication adherence behavior, the PhenX
Tobacco Smoking Status Questionnaire for Adults, and the PhenX Alcohol 30 Day
Quantity and Frequency Questionnaire [18]. Randomization to Immediate and Delayed
treatment was stratified based on PHQ-9 score (5-9, 10-14, and 15-19) and blocked in
groups of 10. Treatment assignments were sealed in an opaque envelope and shuffled and
then numbered and opened in that order. The principal investigator (PI) assigned the
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participants to their randomization order. The PI also gave the volunteers the supplements
at either week 1 or week 7, based on randomization, and educated each participant on the
dosage and possible side effects. Data were collected every 2 weeks via telephone and
included the PHQ-9, GAD-7, questions about changes in medications, changes in
treatment for depression, and side effects.
Outcome measures
The primary hypothesis was that magnesium supplementation decreases
symptoms of depression and therefore the primary outcome was the difference in the
change in PHQ-9 scores between baseline and the end of each six-week period
(difference in differences). The PHQ-9 is a validated questionnaire with high sensitivity
and specificity for the diagnosis of depression [13]. The PHQ-9 score can range from 0 to
27, with the following severity scores: 0-4 None; 5-9 Mild; 10-14 Moderate; 15-19
Moderate to Severe; 20-27 Severe. Telephone administration is comparable to in-person
tracking [19].
Secondary outcomes were exploratory and included changes in the GAD-7 score
as well as adherence to the supplement regimen and intention to use magnesium
supplements in the future. GAD-7 score was recorded in the same fashion as the PHQ-9
and has been shown to be a valid indication of anxiety symptoms [16]. The GAD-7 score
can range from 0 to 21, with the following severity scores: 0-4 None; 5-9 Mild; 10-14
Moderate; 15-21 Severe. To assess side effects, participants were asked to compare
symptoms (headache, diarrhea, nausea, constipation, dizziness, oliguria, and polyuria) to
baseline using a standardized 0-4 point scale (none, mild, moderate, or severe). At the
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end of week 12, a pill count was used to calculate adherence to the supplement regimen
and participants were asked whether they planned to continue using magnesium and why.
Data analysis
All data were analyzed based on the intention-to-treat principle. The age and
gender of patients who were contacted but ineligible were compared to those who were
randomized. Baseline characteristics of eligible participants were compared by
randomization group. Student t-tests or Wilcoxon Rank Sum tests were used for
continuous values and Chi-square tests for categorical values.
The change in outcome for each patient was calculated as the last value
measured during that treatment arm minus the last value measured before that treatment
arm. Before crossing over, this was the week 6 measure minus the baseline measure.
After cross-over, this was the week 12 measure minus the week 6 measure. If a week 12
measure was not available, the week 10 or week 8 measure was used. Participants who
did not provide at least one outcome measure in each treatment period were excluded.
Treatment efficacy was assessed as the net improvement in outcome. The mean change in
the outcomes during the 6 weeks of the control (no treatment) period was compared to
the change in scores during the 6 weeks of treatment. Linear regression was used to test
the significance in the net improvement in the outcome while controlling for potential
confounders.
Each potential confounder was tested in a separate univariate linear regression
for association (P<0.05) with the primary outcome and secondary outcome. Potential
confounders were included in multivariate models. We explored the effectiveness of
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treatment among various subgroups using multivariate models. Linear regression
adjusting for randomization and clustering was used to identify adverse effects. Cuzick’s
test of trend [20] was used to explore the relationships between both the Modified
Morisky score and treatment response with adherence. A two-sided P<0.05 was
considered statistically significant. All analyses were completed using Stata14·1 (College
Station, TX).
The targeted sample size was based on detection of a difference in difference in
PHQ-9 scores of 1.5, which was felt to be clinically significant. The calculation,
assuming a paired t-test, with 84% power, type I error rate of 5%, and a standard
deviation of 5 [21], resulted in a sample size of 50 participants in each group.

Results
Recruitment occurred between June 2015 and May 2016. Of 1,930 patients
identified from medical records, 1,340 (68%) were contacted and 126 (7%) were eligible
and randomized (Figure 3.1). The mean age of the contacted patients was 50 years
compared to a mean age of 52 years in the randomized group (P=0.06). The randomized
group had fewer males than the other contacted patients (38% vs.47%; P=0.07).
Sixty-two participants (49%) were randomized to Immediate Treatment and 64
(51%) to Delayed Treatment (P=0.95). The two groups were similar in all baseline
characteristics except age. The mean age in the Immediate group was 55.6 versus 49.1 in
the Delayed group (P=0.006). All participants commenced treatment based on allocation.
Seven participants withdrew from each group before crossing over (11%) (Figure 3.1).
The most common reason was a change in other depression treatment (n=7) (Table 3.1).
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No participants withdrew due to non-compliance. 108 participants completed all 12
weeks of the study. Four withdrew between week 8 and 12; their last results recorded
before withdrawal were included in the final sample, resulting in 112 participants
analyzed (Figure 3.1). The characteristics of the final analyzed sample appear in Table
3.2. The Immediate group was similar to the Delayed group except that they were 5.1
years older P=0.04).The characteristics of the 14 subjects who withdrew before crossing
over were similar in all measured characteristics to the 112 in the final sample except that
they were more anxious (GAD-7 12.5 vs. 8.6; P=0.01). There were no significant
differences in age, gender, race, smoking, alcohol consumption, baseline PHQ-9 score,
Modified Morisky score, or use of depression therapies at the time of randomization.
Outcomes
Unadjusted PHQ-9 depression scores improved during magnesium treatment
(-4.3 points; 95% confidence interval (CI) -5.0, -3.6), but not during the control period
(-0.1; CI -0.9, +0.7) for the final analyzable cohort of 112 adults. The net improvement
was -4.2 points (CI -5.4, -2.9; P<0.001). Participants who were randomized to Immediate
Treatment first experienced a decrease in PHQ-9 score within 2 weeks; their scores
increased slightly towards baseline during the 6 weeks of control (Figure 3.2). Those in
the Delayed Treatment group experienced a slight improvement in PHQ-9 score during
the control weeks and a further improvement during the active treatment.
Age, gender, race, smoking status, drinks of alcohol per week, adherence to the
supplement regimen, and other treatments for depression were not associated with
response to treatment and were not included in the adjusted model. Mean PHQ-9 change
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during the control weeks, randomization order, and use of selective serotonin reuptake
inhibitors (SSRI) were retained in the multivariate analyses. When adjusted for these
potential confounders, the net improvement with supplementation was -6.0 points (CI 7.9, -4.2; P<0.001). See Table 3.3. Data for all participants (N=126) follow a similar
pattern (Table 3.4). Unadjusted GAD-7 anxiety scores improved during magnesium
supplementation (-3.9 points; CI -4.7, -3.1), but worsened during the control period
(+0.8; CI +0.02, +1.6) for a net benefit of -4.7 points (CI -6.0, -3.3; P<0.001) (Figure
3.3). After adjustment for potential confounders (Table 3.3), the net improvement in
anxiety with magnesium supplementation was -4.5 points (CI -6.6, -2.4; P<0.001).
Again, the data are similar for all participants as well (Table 3.4).
Subgroup analyses were performed using the adjusted models of the association
of magnesium with PHQ-9 and GAD-7 scores. Subgroups were defined by gender, age
above or below 55, PHQ above or below 9, GAD above or below 9, use of any
antidepressant medications, use of specific medications (SSRIs, selective norepinephrine
reuptake inhibitors, bupropion, monoamine oxidase inhibitors, antipsychotics), use of
behavioral therapy or counseling, and adherence above or below 80% by pill count. The
analyses indicated that magnesium was effective in all subgroups (Table 3.3).
Participants were less likely to report headaches while taking magnesium
compared to the control period (unadjusted mean headache score 0.41 vs. 0.57 on the 0-3
scale). The adjusted difference was -0.16 (CI -0.25, -0.03; P=0.013). There was no
difference in the reporting of diarrhea, constipation, nausea, dizziness or urinary
symptoms (Table 3.5). Using the adjusted model, we explored the effect of magnesium
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supplementation on the answers to individual PHQ-9 and GAD-7 items. All items in the
PHQ-9 improved significantly during active treatment except question 8 (abnormal
movement speed) and question 9 (thoughts of suicide). Of note, question 9 was positive
on only 3 of 892 occasions. The only GAD-7 questions that did not improve significantly
were questions 1 (feeling nervous, anxious, or on edge) and 5 (experiencing restlessness).
Percent adherence in the Immediate Treatment group (83%) and Delayed
Treatment group (82%) were similar (P=0.85). Treatment response for both the PHQ-9
and GAD-7 tended to be greater with increased adherence; however, the trend was not
significant for either at P=0.19 and P=0.64, respectively.
When asked whether they would take magnesium in the future, 68 (61%)
answered yes, 22 (20%) answered maybe and 22 (20%) answered no. The most common
reasons for a positive answer were “the magnesium helped my mood” (58%) and “it
helped in other ways” (23%), such as by increasing energy, decreasing constipation, and
decreasing muscle aches and cramps. The most common reason for a negative response
was that “magnesium did not help mood” (46%), followed by side effects (20%). The
most common side effect, diarrhea, was reported by 8 participants.

Discussion
This trial was conducted to test the efficacy and safety of over-the-counter
magnesium and to determine its role in the treatment of depression. Consumption of 248
mg of elemental MgCl2 daily for 6 weeks improved depression scores by a statistically
and clinically significant mean of 6 points and anxiety symptoms by over 4 points. This
effect was not due to natural history, regression to the mean, or confounding, and was
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seen in a wide range of patients with varying ages, co-treatments, and severity of baseline
symptoms. The similar effects seen in the univariate and multivariate models indicates
that the potential confounders had little impact on the estimates of treatment effect.
As with other studies, [8, 11, 22] the improvement in symptoms was seen within
weeks. The effect was somewhat diminished within 2 weeks of stopping
supplementation, indicating relatively quick clearance as well. Although females are
more likely to be diagnosed with depression [23], there was no difference in effect based
on gender. The finding that high and low adherence subgroups had similar improvement
suggests that a smaller dose may suffice with less risk for side effects and lower cost.
Adverse effects were not so severe as to lead to discontinuation except in one
case in which nausea and lethargy led to withdrawal after two weeks. Participants did
report experiencing other clinically significant, and well documented, positive effects of
taking magnesium, such as decreases in headaches and muscle cramps [24]. The fact that
nearly all specific PHQ-9 and GAD-7 items improved significantly while on treatment
corresponds with the qualitative reports.
Although the association between magnesium and depression is well
documented, the mechanism is unknown. However, magnesium plays a role in many of
the pathways, enzymes, hormones, and neurotransmitters involved in mood regulation
[25]. It is a calcium antagonist and voltage-dependent blocker of the N-methyl-Daspartate channel which regulates the flow of calcium into the neuron [26]. In low
magnesium states, high levels of calcium and glutamate may deregulate synaptic
function, resulting in depression [9]. Depression and magnesium are also both associated
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with systemic inflammation [27, 28]. The finding that those participants taking an SSRI
experienced an even greater positive effect points toward magnesium’s possible role in
augmenting the effect of antidepressants. Since the mechanism of magnesium’s role in
depression is still not clear, it is difficult to say why this relationship with antidepressants
may exist. In a sample of treatment resistant depressed patients with normal magnesium
levels, those with high normal magnesium levels had a more robust response to
antidepressants [29]. In another study, severity of depression correlated with reduced
intracellular magnesium, and cellular levels normalized after successful treatment with
antidepressants [30]. Patients may have normal plasma concentration of magnesium yet
have depleted intracellular stores [31]. There may also be differential effects for SSRIs
compared to other antidepressants. Some evidence to support adjunctive use of other
nutraceuticals with antidepressants exists. The mechanism may be related to their antiinflammatory properties or role in NMDA and glutamate activity [32]. Magnesium
supplementation may allow for lower antidepressant dosage or avoid the need for use of a
second medication, both of which could reduce overall side effect burden.
Implications for Practice
The net improvement in PHQ-9 score of 6 points is statistically and clinically
significant. A change in score of 5 or greater reflects a clinically relevant change in
individuals receiving depression treatment. After 6 weeks of psychological counseling, a
drop in 5 points from baseline PHQ-9 indicates the treatment response is adequate and no
treatment change is needed. The same guidelines can be applied to 4 weeks of an
adequate dose of an antidepressant.[33] Magnesium supplementation provides a safe, fast
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and inexpensive approach to controlling depressive symptoms. Most patients who
experience improvement do so within two weeks of starting supplements. Oral
magnesium supplementation is safe in adults with normal kidney function who are not
taking medications that interact with the supplement and when used in dosages below the
upper tolerable limit set by the Institute of Medicine (350 mg elemental magnesium per
day) [34]. Hypermagnesemia is most commonly associated with the combination of
impaired renal function and excessive intake of nonfood magnesium; few serious adverse
effects are reported until very high doses are ingested [34].
Similar to national surveys [35], some participants with depression were not on
any treatment. There are many barriers to treatment for depression including stigma
associated with diagnosis, cost, side effects, non-adherence, and loss to follow-up [36].
Magnesium supplements do not come with the added stigma associated with other
therapies and, while monitoring response is still important, the risk of side effects is not
as great as from antidepressants. Over-the-counter magnesium can be offered as an
alternative therapy to those patients hesitant to begin antidepressant treatment and is
easily accessible without a prescription for around $14.00 per month.
Strengths
This is the first clinical trial done on magnesium for depression in the U.S.
Exclusion criteria were minimal, increasing generalizability, and it used a well-absorbed
form of magnesium. The paired analysis allowed each subject to serve as his or her own
control, minimizing variance and improving statistical power. Random assignment of
treatment order allowed for controlling for regression to the mean as an explanation for
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the apparent treatment effects. Enrolling patients over a full year minimized the effects of
seasonal changes in depression. The withdrawal rate was low and adherence was high,
confirming patient reports of high acceptability.
Limitations
There was no placebo arm and randomization was not blinded for either the
study team or the volunteer. The use of placebo and blinding are essential for a study that
seeks to understand the mechanism of action of an intervention. However, they are not
useful when the research seeks to assess the presence and magnitude of the effect of an
intervention. Whether magnesium works because it induces a physiological change in the
subject, or only because of the placebo effect (or a combination of the two), it remains
that subjects do report better levels of depression and anxiety when taking magnesium
than when not.
Enrolling patients with depression listed on their medical chart resulted in
missing people with undiagnosed depression or who do not use Primary Care. PCPs may
have introduced selection bias by differentially disapproving patients they thought were
unlikely to be open to alternative treatments. This may not be an important limitation to
generalizability since nutraceuticals would probably not be recommended for these
patients anyway. The low response rate to our letter of invitation and follow up calls may
have also introduced selection bias.
The study excluded subjects with malabsorption because the main known side
effect of magnesium is diarrhea. However, because diarrhea was rare in the study, it
would be worth determining the tolerance and effect in those with GI disease. Some of
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the subgroups are small, limiting our ability to detect variation in efficacy, although none
was seen. Due to the makeup of the local community, the study population lacked racial
diversity.
Although improvement in symptoms occurred within two weeks and was
maintained while on treatment, long-term effectiveness is unknown and longer trials are
needed.
Measurement of serum magnesium was outside the scope of the study. A recent
meta-analysis of observational studies found an overall 1.3-fold increased risk of
depression in people with hypomagnesaemia [37] yet a previous meta-analysis was
inconclusive [38]. It is not clear if hypomagnesaemia influences the efficacy of
magnesium supplementation for depression.

Conclusions
Daily supplementation with 248 mg of elemental magnesium as four 500 mg
tablets of magnesium chloride per day leads to a significant decrease in depression and
anxiety symptoms regardless of age, gender, baseline severity of depression, or use of
antidepressant medications. While the cross over design of this trial is robust in
controlling for internal biases, it would be reassuring to see the results replicated in larger
clinical trials that test long term efficacy and provide additional data on subgroups.
However, this efficacy trial showed magnesium supplements may be a fast, safe, and
easily accessible alternative, or adjunct, to starting or increasing the dose of
antidepressant medications.

76

Figure 3.1 Consort diagram
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Reason for withdrawal

Week
2

Week
4

Week
6

⨉

Table 3.1 Withdrawals by reason and time point
Week Week
8
10

Week
12

Total

Cross-over

Treatment Change for
3
3
1
2a
2a
11
Depression
1
1
Side Effects
1
1
Change in Health Status
1
1
Personal Reasons
1
1
2
No Reason Given
1
1
2
Lost to Follow Up
Total number of
5
5
4
0
2a
2a
18
withdrawals
a
These participants were included in the final analysis using their last recorded values.
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Table 3.2 Demographic characteristics of final sample (N=112)
Randomization Group
P-Value
Characteristic
Immediate
Delayed
(N=55)
(N=57)
Age, mean (SD)
55.2 (12.3)
50.1 (13.0)
0.038
Male Gender, N (%)
22 (40%)
22 (36%)
>0.99
Self-Report White Race, N (%)
53 (96%)
56 (98%)
0.62
Current Smoker, N (%)
7 (13%)
8 (12%)
>0.99
Servings of Alcohol Per Week, mean (SD)
3.3 (5.0)
4.9 (7.8)
0.19
Current Treatment for Depression, N (%)
No Treatment
14 (25%)
17 (30%)
0.68
Self-management
1 (2%)
1 (2%)
>0.99
Non-pharmacologic Therapy
14 (26%)
11(19%)
0.50
One or more medications
35 (64%)
35 (61%)
0.85
Selective Serotonin Reuptake Inhibitors
19 (35%)
22 (39%)
0.70
Selective Norepinephrine Reuptake
Inhibitors
8 (15%)
8 (14%)
>0.99
Tricyclic
2 (4%)
1 (2%)
0.61
Bupropion
7 (13%)
9 (16%)
0.80
Monoamine Oxidase Inhibitors
0
0
Antipsychotic
0
2 (4%)
0.50
Baseline Patient Health Questionnaire-9
Depression Score, mean (SD)
10.7 (3.7)
10.6 (3.8)
0.84
Baseline Generalized Anxiety Disorder-7
Anxiety Score, mean (SD)
8.6 (5.1)
8.7 (5.4)
0.92
Modified Morisky Score, mean (SD)
2.9 (0.9)
2.9 (1.0)
0.91
N=number; SD = standard deviation.
P-values calculated by Chi-square for categorical values and two-sample t-test or Wilcoxon
Rank Sum for continuous values.
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Figure 3.2 Patient Health Questionnaire-9 over time by group.

The individual box plots show the distribution of PHQ-9 scores by week in each
randomization group. The middle line of each box represents the median score.
The boxes range from the 25th to the 75th percentile. The whiskers demonstrate the
range of scores with outliers shown by small circles.
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Table 3.3 Adjusted net improvement with magnesium

All
subjects

Magnesi
um
Control

N
112

Change
-4.9

112

+1.1
-6.0

Net Improvement

Subgroups
Gender
Age

Baseline
PHQ-9
Baseline
GAD-7

Adherence

PHQ-9
95% CI
-6.0, -3.9

P
<0.001

Change
-3.6

GAD-7
95% CI
-4.9, -2.3

-0.1, +2.3

0.08

+0.9

-0.4, +2.1

-7.9, -4.2

<0.001

-4.5

-6.6, -2.4

<0.00
1

95% CI
-6.4, -1.1

P
0.003

95% CI
-9.1, -4.0

P
<0.001

Net
Improve
ment
-3.8

P
<0.00
1
0.17

Female

68

Net
Improvement
-6.6

Male

44

-5.3

-7.6, -3.1

<0.001

-5.5

-8.9, -2.1

0.001

<55
years
>55
years
<9

55

-5.3

-7.9, -2.8

<0.001

-5.1

-8.6, -1.5

0.002

57

-6.5

-9.0, -4.1

<0.001

-4.0

-6.6, -1.5

0.001

49

-4.7

-6.3, -3.2

<0.001

-3.1

-4.8, -1.3

>9

63

-7.2

-10.1, -4.2

<0.001

-5.6

-9.2, -2.1

<0.00
1
0.001

<9

68

-4.7

-6.8, -2.6

<0.001

-2.2

-4.0, -0.5

0.005

>9

44

-8.2

-11.0, -5.3

<0.001

-8.3

-12.6, -3.9

Low

56

-5.3

-8.2, -2.5

<0.001

-3.3

-5.9, -0.6

<0.00
1
0.008

High

56

-6.6

-8.7, -4.6

<0.001

-5.7

-8.7, -2.7

PHQ-9 = Patient Health Questionnaire-9; GAD-7 = Generalized Anxiety Disorder-7;
CI = confidence interval.
a
Net Improvement = change in outcome during magnesium treatment – change in
outcome during control.
All results adjusted for mean PHQ-9 score during control weeks, treatment order
(Immediate vs. Delayed), and selective serotonin reuptake inhibitor (SSRI) therapy.
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<0.00
1

Table 3.4 Unadjusted PHQ-9 and GAD-7 scores by event for all participants (N=126)
Patient Health Questionnaire-9
Randomized Treatment
Assignment
Event
Immediate Delayed
Total
Baseline, mean
10.9
10.8
10.8
SD
3.8
3.9
3.8
N
62
64
126
Week 2, mean
7.0
9.1
8.1
SD
4.7
4.9
4.9
N
60
63
123
Week 4, mean
5.8
8.9
7.4
SD
4.3
5.4
5.1
N
59
61
120
Week 6, mean
5.1
9.2
7.1
SD
3.9
5.6
5.2
N
57
57
114
Week 8, mean
6.1
6.8
6.5
SD
4.4
4.9
4.6
N
55
57
112
Week 10, mean
6.5
6.6
6.5
SD
3.9
4.5
4.2
N
52
56
108
Week 12, mean
6.3
6.3
6.3
SD
4.6
5.4
5.0
N
52
56
108
SD=standard deviation; N=number
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Generalized Anxiety Disorder-7
Randomized Treatment
Assignment
Immediate
Delayed
Total
8.9
9.2
9.0
5.1
5.6
5.3
62
64
126
5.7
8.3
7.0
4.7
5.4
5.2
60
63
123
4.9
7.8
6.4
4.4
5.6
5.2
59
61
120
4.4
9.2
6.8
4.0
5.9
5.6
57
57
114
5.5
6.2
5.9
4.5
5.5
5.0
55
57
112
5.3
5.8
5.5
4.3
5.4
4.9
52
56
108
5.2
5.8
5.5
4.9
5.8
5.3
52
56
108

Figure 3.3 Generalized Anxiety Disorders-7 over time by group.

The individual box plots show the distribution of PHQ-9 scores by week in each
randomization group. The middle line of each box represents the median score. The
boxes range from the 25th to the 75th percentile. The whiskers demonstrate the range
of scores with outliers shown by small circles.

83

Table 3.5 Adverse effects during treatment.a

Adverse effect
Headache
Diarrhea
Nausea
Constipation
Dizziness
Oliguria
Polyuria

Unadjusted
Control Magnesium Difference
0.57
0.41
-0.16
0.32
0.29
-0.02
0.22
0.24
+0.02
0.20
0.20
+0.00
0.24
0.22
-0.02
0.04
0.07
+0.03
0.11

0.16

+0.05

Difference
-0.14
-0.01
+0.02
-0.00
-0.02
+0.03

Adjustedb
95% CI
-0.25, -0.03
-0.11, +0.08
-0.07, +0.11
-0.08, +0.07
-0.09, +0.06
-0.02, +0.08

P
0.01
0.79
0.64
0.97
0.66
0.19

+0.05

-0.01, +0.11

0.09

CI = confidence interval.
a
Mean values of biweekly reports on a 0 to 4 scale.
b

Adjusted for mean PHQ-9 score during control weeks, treatment order
(Immediate vs. Delayed), use of SSRIs,
and clustering within participant.
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